Click below to view each DFP profile
As profile information becomes available for each DFP, the panel name will link to additional information.
To access the member directory and contact a specific panel chair/co-chair, log in and select Member Search under the Membership tab.
ETC on Artificial Intelligence (AI)
Thank you to all who participated in the SAR AI Challenge!
The AI Challenge received over 50 submissions encompassing 30 institutions and 4 countries. Each submission was reviewed by members of the AI ETC for technical innovation and feasibility and the relevant DFP members for potential impact. The reviewers were blinded and over 70 of them were involved in the scoring. This challenge has generated tremendous discussion, education and excitement around AI for all abdominal imaging.
A Very Special Thank You to Bracco and ACR Data Science Institute for Their Support of the 2020 SAR TANK!
SAR Tank 2020 Winner – Expert’s Choice
Expedited and Improved Detection of Thromboembolism on CT – Roshan Modi
SAR Tank 2020 Winner – People’s Choice
Building an Artificial Intelligence (AI) Use Case for Determining the Location and Likelihood of Clinically Significant Prostate Cancer using mpMRI – Masoom Haider & Baris Turkbey
SAR Tank 2020 Runner Up
AI TI-RADS Classifier & Automated Recommendations for Thyroid Nodules – Ben Wildman-Tobriner
SAR Tank 2020 Honorable Mentions
Outstanding submissions given Honorable Mention were invited to submit a video presentation to experts around the world showing that their idea is worth working, not just because of the clinical needs but that the application of AI to this problem will be successful as well!
SAR AI Masters Class
The SAR 2020 AI Masters Class material is located here: https://github.com/abdominalradiology
The SAR Crohn’s disease Disease-Focused Panel mission is to foster a close collaborative environment among radiologists and clinical colleagues involved in the care of patients with Crohn’s disease. Our aim is to develop educational materials, joint recommendations, and scientific collaborations that will help advance the knowledge in the field.
- To improve patient care through the dissemination of up to date knowledge related to Crohn’s disease.
- To collaborate with other organizations such as the ESGAR (European Society of Gastrointestinal and Abdominal Radiology), the AGA (America Gastrointestinal Association), CCF (Crohn’s and Colitis Foundation), the SSAT (Society for Surgery of the Alimentary Tract) and NASPGHAN (North American Society for Pediatric Gastroenterology, Hepatology and Nutrition) to develop consensus statements and educational or scientific publications related to the current up to date knowledge in the field.
- Collaborate with the ACR (American College of Radiology) on developing and updating the practice guidelines for the performance of CT and MR enterography.
- Leadership and membership
SAR CD-DFP Members:
Mahmoud M. Al-Hawary, University of Michigan/Michigan Medicine
Sudha A. Anupindi, Children’s Hospital of Philadelphia, University of Pennsylvania
Mark E. Baker MD, Cleveland Clinic Foundation
David H. Bruining, Mayo Clinic (Consultant Gastroenterologist)
Manjil Chatterji, Weill Cornell Medicine
Bari Dane, New York University Langone Health
Kassa Darge, Children’s Hospital of Philadelphia & University of Pennsylvania
Parakkal Deepak, Washington University (Consultant Gastroenterologist)
Jonathan R. Dillman, Cincinnati Children’s Hospital Medical Center, University of Cincinnati
Jeff L. Fidler, Mayo Clinic
Joel G. Fletcher, Mayo Clinic
Namita S. Gandhi, Cleveland Clinic Foundation
Michael S. Gee, Massachusetts General Hospital
Joseph R. Grajo, University of Florida College of Medicine
David J. Grand, Rhode Island Hospital
Flavius F. Guglielmo, Thomas Jefferson University Hospital
Amy Hara, Mayo Clinic
Chenchan Huang, New York University Langone Health
Tracy A. Jaffe, Duke University Medical Center
Seong Ho Park, Asan Medical Center, Seoul, South Korea (SAR International Member)
Jordi Rimola, Hospital Clinic of Barcelona, Barcelona, Spain (ESGAR Member)
Cynthia Santillan, University of California San Diego
Jorge A. Soto, Boston University Medical Center
Bachir Taouli, Icahn School of Medicine at Mount Sinai
Stuart A. Taylor, University College London, London, UK (ESGAR Member)
Benjamin M. Yeh, University of California San Francisco
Lucy Muinov, University of Nebraska Medical Center Radiology
David Einstein, Beth Israel Deaconess Medical Center
Dean Maglinte, MD, Indiana University
Alec Megibow, MD, New York University Langone Health
Joel Platt MD, University of Michigan
Dushyant V. Sahani MD, University of Washington
- General updates and active projects
Crohn’s DFP members have presented on imaging of Crohn’s disease at numerous imaging and gastroenterology meetings including Radiological Society of North America, Society of Abdominal Radiology, Digestive Disease Week, Crohn’s and Colitis Congress, North American Society For Pediatric Gastroenterology, Hepatology & Nutrition, and The Society for Pediatric Radiology. DFP members will be presenting a workshop on imaging of Crohn’s disease at the 2020 meeting of the Radiological Society of North America (RSNA). Members are also authoring a series of articles to be published in Topics in Magnetic Resonance Imaging in 2021.
- NEW! December 2020: Crohn’s Disease Hands-On Workshop- Track Chair: Judy Yee, RSNA Annual Meeting, Chicago IL
- CTE & MRE: Essentials of a Great Exam- Michael Gee
- CD: Updates in Nomenclature and Reporting- Flavius Guglielmo
- Focused US in CD: When, How, and Why?- Jonathan R. Dillman
- SAR Crohn’s Disease DFP Webinar – date to be determined
- March 2019: Advanced Small Bowel Imaging Hands-on Workshop, SAR Annual Meeting, Orlando FL
- March 2018: Advanced Small Bowel Imaging Hands-on Workshop, SAR Annual Meeting, Scottsdale AZ
- March 2016: Advanced Small Bowel Imaging Hands-on Workshop, SAR Annual Meeting, Waikoloa HI
- March 2015: Advanced Small Bowel Imaging Hands-on Workshop, SAR Annual Meeting, San Diego CA
- Article database / DFP publications
Crohn’s DFP Publications
- Small Bowel Crohn Disease at CT and MR Enterography: Imaging Atlas and Glossary of Terms. RadioGraphics March/April 2020
- CT and MR Enterography Protocols and Techniques: Survey of the Society of Abdominal Radiology Crohn’s Disease Disease-Focused Panel. Abdominal Radiology January 2020
- Consensus Recommendations for Evaluation, Interpretation, and Utilization of CT & MR Enterography in Patients with Small Bowel Crohn’s Disease. Radiology & Gastroenterology March 2018
- CT enterography for Crohn’s disease: optimal technique and imaging issues Abdominal Imaging June 2015
- MR enterography in Crohn’s disease: current consensus on optimal imaging technique and future advances from the SAR Crohn’s disease-focused panel. Abdominal Imaging June 2015
- CT and MR enterography in Crohn’s disease: current and future applications. Abdominal Imaging June 2015
- Pediatric inflammatory bowel disease: imaging issues with targeted solutions. Abdominal Imaging June 2015
- Social media
- Templates and Imaging Protocols
ACR-SAR-SPR Practice Parameters
Crohn’s Disease MR or CT Dictation Template
- Click here to reach the MR or CT enterography structured report dictation template created by members of the SAR Crohn’s DFP on the RSNA RadReport website.
To support abdominal radiologists performing a wide variety of cross-sectional procedures with evidence-based standards of practice and educational initiatives.
- To create a platform for multi-institutional research collaborations.
- To develop educational materials which will ensure best clinical practices for different types of CSIR procedures.
- To develop guidelines for pre-, intra-, and post-procedure patient management specific to the different types of procedures.
- To develop guidelines/criteria for biopsy documentation that would ensure appropriate radiological-pathological follow-up.
- To collaborate with SAR DFPs to enhance patient care and outcomes by promoting
General updates and active projects
- Published guidance on reorganizing CSIR services during COVID-19 pandemic
- Working on special CSIR section in Abdominal Radiology
- Post-procedure observation time recommendations
- Personal protective equipment usage for CSIR procedures
- Abdominal Radiology statement on current state and future of CSIR within abdominal radiology
Workshops –current and future only
CSIR ETC hands-on workshop
Article database Fananapazir G, Lubner MG, Mendiratta-Lala M, Wildman-Tobriner B, Galgano SJ, Lamba R, Hinshaw JL, Brook OR.
Reorganizing Cross-Sectional Interventional Procedures Practice During the Coronavirus Disease (COVID-19) Pandemic. American Journal of Roentgenology. 2020 Apr 25:1-5.
Social media Twitter: @CSIRETC
To improve patient care of those with pelvic pain and endometriosis through alliances with clinicians, improvements in radiology practice, and by advancing knowledge through research studies.
June 2020, Volume 45, Issue 6
Issue Edited by Wendaline M. VanBuren
The June 2020 issue of Abdominal Radiology features a special section on Endometriosis including 27 articles, many contributed by the Endometriosis DFP, including important topics ranging from consensus papers on endometriosis lexicon and pelvic MRI technique to post surgical and medical treatment appearance of the pelvis and more. Visit the issue for complete information.
Resources for Radiologists
Imaging and Reporting
- Office on Women’s Health (US Department of Health and Human Services)
- To form alliances with gynecologists and other physicians in order to improve awareness of endometriosis as a cause of chronic pelvic pain and infertility and to improve interdisciplinary collaboration in approaching this entity.
- Increased communication with referring physicians and practitioners, to improve the use of imaging tools to diagnose and manage patients with endometriosis to ultimately improve outcomes.
Radiology Practice Mission
- To share evidence-based practice standards for imaging techniques to detect and classify endometriosis.
- Support study interpretation guidance utilizing interactive case based examples, didactic lectures, and workshops including intra-operative correlation.
- Standardize reporting with structured templates for reporting imaging studies for patients with chronic pelvic pain and endometriosis.
To promote and encourage imaging research which is clinically relevant, and in-line with practice standards and developing innovations in the treatment and management of endometriosis.
Current Active Projects:
- Endometriosis Education Collaboration with RSNA Case Collection
- Endometriosis Imaging Webinar hosted by SAR this winter
- Contributions to Educational Programming for the upcoming SAR Annual Meeting
Leadership and Memberships
Wendy Van Buren, MD
Myra Feldman, MD
Endometriosis DFP Subdivisions:
Consultant Gynecologist: Tatnai Burnett, MD
Consultant Pathologist: Jennifer Brainard, MD
Scientific Chair: Wendy VanBuren, MD
Education Chair: Myra Feldman, MD
Mentorship Chair: Nicole Hindman, MD
Website and Social Media Chair: Angela Tong, MD
International Representative: Luciana Chaime, MD (Brazil)
Endometriosis Disease-Focused Panel Members:
Multidisciplinary Approach for Gastroesophageal Reflux (GERD) DFP
In current medical practice, endoscopy has become the primary diagnostic test for evaluating patients with gastroesophageal reflux disease (GERD), while fluoroscopy has been underutilized in the diagnostic work-up of these individuals. The decreasing role of fluoroscopy is related to a variety of factors, including: 1) the wide variability in fluoroscopic training across academic institutions and, as a result, a dwindling pool of radiologists who have the skill or experience needed to perform and interpret high-quality fluoroscopic examinations; 2) an “endoscopy first” mentality by many gastroenterologists that undervalues barium esophagography; and 3) lack of investment in research and development of fluoroscopic contrast agents by academic radiology and industry as well as recurring problems related to shortages or even discontinuation of essential barium products. Despite these issues, barium esophagography remains a relatively inexpensive and noninvasive global examination that provides valuable information about swallowing function, esophageal motility, morphologic abnormalities in the pharynx and esophagus, and GER, potentially obviating the need for fiberoptic examination of swallowing (FEES), manometry, ear-nose-throat (ENT) examination, endoscopy, and 24-hour pH monitoring.
The mission of the panel is to establish the importance of a multidisciplinary approach for GERD that recognizes the important role of barium esophagography in conjunction with endoscopy and other diagnostic tests. This panel will emphasize the value-added service of fluoroscopic examinations in evaluating patients with GERD by providing guidelines for radiologists based on available scientific literature, by addressing educational gaps in fluoroscopic training for performing and interpreting barium esophagograms, by partnering with industry to foster research and development in barium esophagography and develop strategies for increasing awareness of the value of fluoroscopy, and by working in conjunction with gastroenterology to develop a broad consensus about an optimal multidisciplinary approach for evaluating patients with GERD.
- Partner with gastroenterology, specifically American Gastroenterological Association (AGA) and possibly American Society for Gastrointestinal Endoscopy (ASGE), but that will need more discussion and exploration. Other potential collaborating societies include the Dysphagia Research Society, to develop a consensus statement about an optimal interdisciplinary approach for evaluating patients with GERD that could be published in Abdominal Imaging, the official journal of SAR, and on the SAR website.
- Develop a variety of educational tools for performing and interpreting barium esophagograms, including A) swallowing examination protocols for GERD that could be made available on the SAR website; B) plenary sessions/workshops at the annual SAR meeting and other radiology conferences; C) review articles and tutorials that could be published in Abdominal Imaging or other journals and made available on the SAR website; D) site visits to academic radiology centers for direct observation of the procedures; and E) a series of short, directed video tutorials on how to perform and interpret barium esophagograms in the setting of GERD that could be made available on the SAR website, You-Tube, and other locations
- Partner with industry to develop strategies for increasing awareness of the value of barium esophagography as part of a multidisciplinary approach for GERD.
- Partner with speech pathology to develop guidelines for detecting pharyngeal complications of GERD by careful evaluation of the pharynx or “modified barium swallows” in the appropriate clinical setting.
- Partner with gastroenterology to increase awareness among clinicians about the value of an interdisciplinary approach for GERD by participating in hospital Grand Rounds and annual GI meetings and also contributing review articles to gastroenterology and other clinical journals.
SAR GERD DFP Members:
Laura R. Carucci, M.D., F.A.C.R. (Co-Chair)
Professor of Radiology, Director of MRI and Computed Tomography
Virginia Commonwealth University Medical Center/ Medical College of Virginia
Meg Fynes, M.D. (Co-Chair)
University of Pittsburgh
Cheri L. Canon, M.D., F.A.C.R.
Professor and Chair of Radiology, Witten-Stanley Endowed Chair of Radiology
University of Alabama at Birmingham School of Medicine
David J. DiSantis, M.D.
Arthur Lieber, M.D. Endowed Professor of Diagnostic Radiology
University of Kentucky College of Medicine
Marc S. Levine, M.D.
Emeritus Professor of Radiology
Perelman School of Medicine at the University of Pennsylvania
Angela D. Levy, MD
Professor of Radiology, Director of Ultrasound
Medstar Georgetown University Hospital
Desiree E. Morgan, M.D.
Professor of Radiology and Vice Chair of Education
University of Alabama at Birmingham School of Medicine
David Rosman, MD, MBA
Service Chief, Outpatient and Ambulatory Imaging
Director, GI/GU Fluoroscopy
Massachusetts General Hospital
Stephen E. Rubesin, MD
Professor of Radiology
Perelman School of Medicine at the University of Pennsylvania
Mary Ann Turner, M.D., F.A.C.R.
Professor and Vice Chair of Radiology
Virginia Commonwealth University Medical Center/ Medical College of Virginia
Frank J. Scholz, M.D.
Clinical Professor of Radiology, Tufts University School of Medicine
Lahey Hospital & Medical Center
Ellen L. Wolf, M.D.
Professor of Radiology
Montefiore Medical Center
Jessica G. Zarzour, M.D.
Program Director, Diagnostic Radiology Residency
University of Alabama at Birmingham, Abdominal Imaging Section
David A. Katzka, M.D.
Professor of Medicine, Department of Gastroenterology and Hepatology
Mayo Clinic, Rochester, MN
Mary T. Hawn, M.D., M.P.H.
Professor and Chair of Surgery
Stanford School of Medicine
Bonnie Martin-Harris, Ph.D., CCC-SLP, BCS-S
Professor of Otolaryngology Head & Neck Surgery,
Director of the MUSC Evelyn Trammell Institute for Voice and Swallowing.
Medical University of South Carolina
Julie Peterson, M.S./CCC-SLP
Clinical Sales Specialist for Bracco Diagnostics, Inc
CEO of Sunapsis, Inc. and Bracco Diagnostics, Inc. Consultant
To promote and speed evolution of cross-sectional and other imaging techniques and multidisciplinary guidelines to improve outcomes in patients with overt and occult GI bleeding through rigorous analysis of existing medical evidence, and prospective interdisciplinary research, collaboration and education.
1. Publish a comprehensive review of the radiology and gastroenterology techniques used to diagnose GI bleeding.
2. Establish working relationships with gastroenterology-led medical societies to develop multidisciplinary guidelines for the use of imaging techniques in the diagnosis of overt and occult GI bleeding.
3. Develop SAR-recommended protocols for the optimal performance of the imaging techniques used to diagnose GI bleeding.
Educational Program and Content
1. Develop an online interactive teaching resource to educate radiologists and clinicians on the benefits of imaging techniques. This resource will allow individuals to review cases that demonstrate imaging findings of interesting, unique or subtle cases of GI bleeding and emphasize the importance of imaging in the diagnosis.
2. Develop an online database of articles to help promote education and provide a rapid resource for clinical practice and research.
Impact on Research
1. The formation of the DFP will provide an opportunity and mechanism for discussing and planning possible multicenter studies describing pathology, benefits of cross-sectional imaging and assessing cost-effectiveness.
SAR GI Bleeding DFP Members:
Chair: Jeff Fidler, Mayo Clinic; email@example.com
Co-Chair: Jorge Soto, Boston University; firstname.lastname@example.org
Brian Allen, Duke University; email@example.com
Mark Anderson, Mark.Anderson@MGH.HARVARD.EDU
Olga Brook, Beth Israel Deaconess Medical Center; firstname.lastname@example.org
Mike Gee, Massachusetts General Hospital; email@example.com
Flavius (Buddy) Guglielmo, Thomas Jefferson University; firstname.lastname@example.org
David Grand, Brown University; email@example.com
Martin Gunn, University of Washington; firstname.lastname@example.org
Ashish Khandelwal; Mayo Clinic; email@example.com
Vijay Ramalingam; Ochsner Clinic Foundation; firstname.lastname@example.org
Farnoosh Sokhandon, Beaumont Health; email@example.com
Mike Wells, Mayo Clinic; firstname.lastname@example.org
Don Yoo, DYoo@Lifespan.org
Chair: Jeff Fidler
Co-chair: Jorge Soto
Clinical practice chair: Jeff Fidler
Scientific chair: Jorge Soto
Education chair: Mike Wells, Alvaro Huete
Publications chair: Buddy Guglielmo, Farnoosh Sokhandon
Website chair: Martin Gunn
Social media chair: Ashish Khandelwal
ACR Liaison: Jorge Soto
American College of Gastroenterology (ACG) Liaison: Lisa Strate, Jeff Fidler
American Gastroenterological Association (AGA) Liaison: Lisa Strate, David Bruining, Jeff Fidler
American Society for Gastrointestinal Endoscopy (ASGE) Liaison: David Bruining, Lisa Strate, Jeff Fidler
Society of Interventional Radiology (SIR) Liaison: Vijay Ramalingam
American Society of Emergency Radiology (ASER) Liaison: Jorge Soto
Occult GI bleeding
Overt GI bleeding
Small bowel neoplasms
Consensus Recommendations for CTA Technical Parameters in the Evaluation of Acute Overt Gastrointestinal Bleeding — Abdom Radiol 2019 Sep;44(9):2957-2962, doi: 10.1007/s00261-019-02131-y
Current Management Guidelines
Iron overload is a common diffuse liver disease affecting patients with genetic hemochromatosis, transfusion-dependent anemias (sickle cell, thalassemia, aplastic anemia), and hematologic malignancies, and may lead to hepatic dysfunction and ultimately end-stage liver disease. Liver biopsy has traditionally been considered the gold standard technique to measure liver iron concentration (LIC). However, quantitative imaging techniques are increasingly used to estimate LIC and to inform diagnostic and treatment decisions without the need for invasive liver biopsy.
The mission of this DFP is to improve diagnosis, management, and outcomes of patients with hepatic iron overload by: (1) establishing interdisciplinary consensus guidelines for imaging techniques; (2) educating radiologists on recommended patient selection, image acquisition, analysis and interpretation methods; and (3) promoting interdisciplinary and multicenter research.
A variety of quantitative imaging techniques for hepatic iron overload, currently mostly MRI-based, have been developed by experts at centers of excellence and are now available for clinical care. However, no practice guidelines have been established to advise how to implement, perform, and interpret these imaging exams outside of these centers of excellence. There is also no currently documented cross-center validation of imaging techniques to help new users to implement methods easily. To fill this unmet need, this DFP will focus on the following specific goals:
- Provide detailed descriptions of the options currently available for imaging-based quantification of hepatic iron in clinical practice
- Provide technical recommendations for optimized image acquisition and post-processing methods
- Provide clinical workflow recommendations, including appropriate patient selection, examination protocols, image interpretation, and reporting
- Through a SAR educational and hands-on workshops: increase radiologists’ awareness of hepatic iron overload and its clinical significance; educate radiologists on the advantages, disadvantages, limitations, biases, and pitfalls of existing imaging techniques and post-processing methods; recommend clinical workflow for image interpretation and reporting
- Develop electronic educational materials for enduring CME activities related to hepatic iron overload
- Engage clinical stakeholders (e.g. hematology, cardiology, gastroenterology), through their respective processional societies, about the SAR-ESGAR multidisciplinary consensus guidelines (see “International” goals below)
- Summarize current knowledge on liver iron quantification imaging and identify gaps in knowledge via systematic reviews /meta-analysis
- Identify priorities for future technical refinement and clinical validation research studies
- Promote and facilitate collaboration for multicenter and multidisciplinary research in hepatic iron overload diagnosis and management
- In collaboration with ESGAR, establish international consensus guidelines on imaging techniques of hepatic iron overload
- Takeshi Yokoo, MD PhD (email@example.com) UT Southwestern; co-chair
- Scott Reeder, MD PhD (firstname.lastname@example.org) Univ. Wisconsin at Madison; co-chair
- Ihab Kamel, MD (email@example.com) Johns Hopkins
- Anil Chauhan, MD (firstname.lastname@example.org) U. Minnesota
- Amikasra (Kasra) Mojtahed, MD (AMOJTAHED@mgh.harvard.edu) MGH*
- Ali Pirasteh, MD (email@example.com) Univ. Wisconsin at Madison*
- Benjamin Henninger, MD (Benjamin.Henninger@i-med.ac.at) Medical University of Innsbruck, Austria
- Luis Marti-Bonmati, MD PhD (firstname.lastname@example.org) La Fe Polytechnics & University Hospital, Valencia, Spain
- Manuela França, MD PhD (email@example.com) Centro Hospitalar do Porto, i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal
- Suraj Serai, PhD (SERAIS@EMAIL.CHOP.EDU) Childrens Hospital of Philadelphia
- Andrew Trout, MD (Andrew.Trout@cchmc.org) Cincinnati Childrens Hospital Medical Center
- Kartik Jhaveri, MD (Kartik.Jhaveri@uhn.ca) University of Toronto
- Cara Morin, MD (firstname.lastname@example.org) St. Jude Children’s Hospital*
Non SAR/ESCAR Consultant(s):
- John Wood, MD PhD (JWood@chla.usc.edu) pediatric cardiology
- Claudia Hillenbrand, PhD (email@example.com) Physics
- Beth McCarville, MD (Beth.McCarville@STJUDE.ORG) Pediatric Radiology
- Jane Hankins, MD (firstname.lastname@example.org) Hematology
- Ralf Loeffler, PhD (email@example.com) Physics
- Richard Ward, MD (Richard.Ward@uhn.ca) Adult Hematology
* Junior Member
Scott Reeder, MD, PhD, Scientific Co-Chair
Takeshi Yokoo, MD, PhD, Education and Practice Co-Chair
Luis Marti-Bonmati, MD, PhD, Liaison to ESGAR
General updates and active projects
Hepatic Iron Overload DFP aims for the evaluation of the scientific evidence on various quantitative imaging techniques for liver iron concentration, as well as promotion of these techniques in clinical practice. Towards the scientific aim, the DFP has been working closely with European Society of Gastrointestinal and Abdominal Radiology (ESGAR) to develop a consensus practice guideline for quantitative MRI for hepatic iron concentration estimation. The writing group was formed in 2018 and aims to publish a white paper in 2021.
Workshops – current and future only
Quantitative MRI of Diffuse Liver Disease (Hands on Workshop 2021)
Hepatocellular Carcinoma Diagnosis Disease Focused Panel
1. To facilitate the adoption of a single system for imaging-based diagnosis and reporting of HCC in North America.
2. To provide radiologists with tools and knowledge to detect and diagnose hepatocellular carcinoma.
- Promote adoption and proper use of LI-RADS, accomplished through:
- Strategic educational endeavors at national and international meetings
- Investigate the preferences of radiologists, clinicians, and surgeons
- Liaising with other Radiology and clinical/surgical societies
- Identify and courage “Radiologist Champions” to disseminate up-to-date information about LI-RADS at their own institutions and local areas.
LEADERSHIP AND MEMBERSHIP:
An enthusiastic group of volunteers from all over North America who participate regularly in the group activities to keep moving forward with the SAR DFP: HCC diagnosis goals! This group includes 9 full professors, 10 associate professors, 10 assistant professors and 3 community radiologists from various academic institutions and private practice centers across North America.
DFP Members – Institution
Robert Marks (co-chair) – Naval Medical Center San Diego
Khaled Elsayes (co-chair) — MD Anderson Cancer Center
Alice Fung – Oregon Health and Science University
Jimmy Lee – University of Kentucky, Chair Social Media
Kedar Jambhekar – University of Arkansas
Sandeep Deshmukh – Thomas Jefferson University
Ryan Ash – University of Kansas
Bijan Bijan – Sutter Medical Foundation
Venkateswar Surabhi – University of Texas
Irene Cruite – Providence Health and Services
Alessandro Furlan – University of Pittsburgh
Joseph Yacoub – Georgetown University
Chandana (Sandy) Lall – University of Florida Jacksonville
Anuradha Shenoy-Bangle – Beth Israel Deaconess Medical Center
Zahra Kassam – Western University
Christopher Lim – University of Ottawa
William Masch – University of Michigan
Shuchi Rogers – Thomas Jefferson University
Amir A. Borhani – University of Pittsburgh
Humaira Chaudry – Rutgers New Jersey Medical School
Clinical/ Surgical Members – Institution
Alan Hemming – Department of Surgery, University of Iowa
Rohit Loomba – Department of Gastroenterology, University of California San Diego Yuko Kono – Department of Gastroenterology, University of California San Diego
Ex-Officio Members – Institution
Claude Sirlin (previous co-chair) – University of California San Diego
Ania Kielar (previous co-chair) – University of Toronto
Victoria Chernyak – Montefiore Medical Center
Richard Do – Memorial Sloan Kettering Cancer Center
Katie Fowler – University of California San Diego
John McGahan – University of California Davis
Mustafa Bashir – Duke University
Elizabeth Hecht – Cornell University
Aya Kamaya – Stanford University
DFP Members-In-Training – Institution
Satheesh Krishna – University of Toronto
Katie Blair – Kaiser Permanente, Walnut Creek Medical Center
Mohab Elmohr – Baylor University
Nikita Consul – Baylor University
GENERAL UPDATES AND ACTIVE PROJECTS:
- Online Liver Imaging Course, 6 week course from April 20 – May 29, 2020 available on YouTube at https://m.youtube.com/channel/UCcpdtNxIM7vlDRdmuWY9URg
- Community Radiologist, Clinician, and Surgeon Survey Study Regarding LI-RADS
- 12 RSNA 2020 Educational Exhibits about LI-RADS
- LI-RADS Case Based Hands-On Workshop, Society of Abdominal Radiology Annual Meeting 2021
- Overview of LI-RADS, Society of Abdominal Radiology Annual Meeting 2021
- Treatment Response in HCC, Society of Abdominal Radiology Annual Meeting 2021
- SAR Hepatocellular Diagnosis DFP Multidisciplinary Webinar, June 2021
- Overview of LI-RADS
- LI-RADS Ancillary Features
- LI-RADS, Is There A Clinical Need?
Facebook: SAR HCC Dx Disease-Focused Panel
TEMPLATES AND IMAGING PROTOCOLS
LI-RADS Technique: https://www.acr.org/-/media/ACR/Files/Clinical-Resources/LIRADS/Chapter-12-Technique.pdf?la=en&hash=3B774BD8A6D0A6ACBD62B2330705FD14
To ensure patients who have undergone locoregional or biological therapy for hepatocellular carcinoma are managed appropriately by enabling radiologists who interpret their post-treatment imaging to positively contribute to their care.
Imaging of cirrhotic patients with HCC both before and after treatment comprises a large part of abdominal radiology imaging volume. In fact, the number of cirrhotic patients is increasing annually in the United States and internationally, with an increased incidence of HCC as well, which is now not only the 5th most common cancer worldwide, but the 5th leading cause of cancer related death in the United States. Thus, HCC treatment response is a vital component of the training and clinical practice of abdominal radiologists. Currently, multiple treatment response classification systems exist, including the newer system termed LI-RADS treatment response.
Incorporating a strategic educational and research support system for abdominal radiologists involved in interpretation of complex cross-sectional imaging after HCC treatment, aligns with the SAR’s mission statement as well as its strategic goals in “providing the highest level of education” and “promoting … best practices in abdominal radiology.” Additionally, as abdominal radiology seeks to unify LI-RADS treatment response with other treatment response classification systems (such as mRECIST), this DFP will help provide multidisciplinary validation of this system by providing a vehicle for more robust research and technical developments through multi-institutional collaboration. This aligns with SAR strategic goal to “promote excellence in scientific discovery.”
Thus, the mission of the SAR HCC treatment response DFP would be to 1) support abdominal imagers through educational initiatives, 2) promote research, and 3) foster inter-societal collaboration. We believe SAR is an essential forum for this mission, as many leaders in hepatic imaging are part of this society.
Improvements in patient Care
- To develop educational material and algorithms which will advance knowledge and facilitate interpretation of complex cross-sectional imaging in patients who have undergone locoregional therapy for HCC in order to ensure best clinical practices and thus improve patient care.
- To collaborate with non-abdominal radiology clinicians, such as interventional radiologists, hepatobiliary surgeons, radiation oncologists and hepatologists, to enhance patient care and outcomes by creating algorithms/guidelines for image interpretation after locoregional therapy, by incorporating relevant patient data which would ensure best overall clinical outcomes.
Improvements/standards for radiology practice
- To create algorithms and templates to facilitate reporting of complex findings after locoregional therapy for HCC in order to improve reporting of these cases in radiology practices.
- To create a platform for national and international multi-institutional research and educational collaborations
Co-Chairs: Mishal Mendiratta-Lala and Vahid Yaghmai
Mishal Mendiratta-Lala (University of Michigan)
Vahid yaghmai (UC Irvine)
Anuradha Shenoy-Bhangle (Beth Israel Deaconess, Harvard)
Richard Do (Memorial Sloan Kettering)
Kim Shampain (University of Michigan)
Roopa Ram (University of Arkansas)
Bradley Spieler (LSUHSC)
Marielia Gerena (Loyola)
Radu Rozenberg (Ottowa Hospital)
Amita Kamath (Mount Sinai)
Rony Kampalath (UC Irvine)
Sadhna Nandwana (Emory)
Ania Kielar (University of Toronto)
Silvia Chang (University of British Columbia)
Leo Tsai (Beth Israel Deaconess, Harvard)
Mustafa Bashir (Duke)
Alison Harris (University of British Columbia)
William Masch (University of Michigan)
Joseph Yacoub (Medstar Georgetown University)
Kathryn Fowler (UCSF)
Eugene Huo (UCSF)
Sandeep Singh Arora (Yale)
Katrina McGinty (University of North Carolina)
Lauren Burke (University of North Carolina)
Sara Lewis (Mount Sinai)
Anum Aslam (University of Michigan)
Mark Maschiocchi (University of Massachusets)
Claude Sirlin (UCSF)
Victoria Chernyak (Montefiore)
SAR 2021 annual meeting:
- Plenary session: Response and Assessment Wednesday 3/24/2021 7-8:30AM
- HCC Treatment Response Overview and Post-Treatment Imaging: Ania Kielar
- Conventional Locoregional Therapy for HCC: from ablation to embolotherapy: Joseph Yacoub
- Radiation Therapy for HCC: Unequivocal assessment of treatment response: Mishal Mendiratta-Lala
- Emerging (or non-traditional) HCC Treatment Options: systemic and biological therapies: Mustafa Bashir
- Response Assessment of Non-HCC Liver Cancers: Sara Lewis
- HCC and HCC Treatment Response DFP combined Hands-on Workshop
- Treatment response assessment of hepatocellular carcinoma: Burke, McGinty
- Easy to Use or IS IT? LI-RADS Treatment Response Algorithm: Challenging Cases: Masch, Shenoy-Bhangle
- The HCC TR DFP has been invited to do an Abdominal Radiology special edition for 2021. There are 16 manuscripts providing a comprehensive background, update and emerging information in respect to HCC treatment response.
- The HCC TR DFP will have two major focus points in 2021.
- Evaluation of the utility, accuracy and validity of the ‘Equivocal’ classification for LIRADS Treatment Response Algorithm
- Evaluation of HCC treatment response assessment after systemic therapy- focus on imaging findings.
- Voizard N, Cerny M, Assad A, Billiard JS, Olivié D, Perreault P, Kielar A, Do RKG, Yokoo T, Sirlin CB, Tang A. Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review. Insights Imaging. 2019 Dec 18;10(1):121. doi: 10.1186/s13244-019-0801-z. PMID: 31853668; PMCID: PMC6920285.
- Shropshire EL, Chaudhry M, Miller CM, Allen BC, Bozdogan E, Cardona DM, King LY, Janas GL, Do RK, Kim CY, Ronald J, Bashir MR. LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy. Radiology. 2019 Jul;292(1):226-234. doi: 10.1148/radiol.2019182135. Epub 2019 Apr 30. PMID: 31038409; PMCID: PMC6614909.
- Do RK, Mendiratta-Lala M. LI-RADS Version 2018 Treatment Response Algorithm: The Evidence Is Accumulating. Radiology. 2020 Feb;294(2):327-328. doi: 10.1148/radiol.2020192484. Epub 2019 Dec 17. PMID: 31846402; PMCID: PMC6996598.
- Kielar A, Fowler KJ, Lewis S, Yaghmai V, Miller FH, Yarmohammadi H, Kim C, Chernyak V, Yokoo T, Meyer J, Newton I, Do RK. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm. Abdom Radiol (NY). 2018 Jan;43(1):218-230. doi: 10.1007/s00261-017-1281-6. PMID: 28780679; PMCID: PMC5771991.
- Gervais DA. LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy. Radiology. 2019 Jul;292(1):235-236. doi: 10.1148/radiol.2019190768. Epub 2019 Apr 30. PMID: 31039077.
- Chaudhry M, McGinty KA, Mervak B, Lerebours R, Li C, Shropshire E, Ronald J, Commander L, Hertel J, Luo S, Bashir MR, Burke LMB. The LI-RADS Version 2018 MRI Treatment Response Algorithm: Evaluation of Ablated Hepatocellular Carcinoma. Radiology. 2020 Feb;294(2):320-326. doi: 10.1148/radiol.2019191581. Epub 2019 Dec 17. PMID: 31845843.
- Zhang Y, Wang J, Li H, Zheng T, Jiang H, Li M, Song B. Performance of LI-RADS version 2018 CT treatment response algorithm in tumor response evaluation and survival prediction of patients with single hepatocellular carcinoma after radiofrequency ablation. Ann Transl Med. 2020 Mar;8(6):388. doi: 10.21037/atm.2020.03.120. PMID: 32355832; PMCID: PMC7186681.
- Abdel Razek AAK, El-Serougy LG, Saleh GA, Shabana W, Abd El-Wahab R. Reproducibility of LI-RADS treatment response algorithm for hepatocellular carcinoma after locoregional therapy. Diagn Interv Imaging. 2020 Sep;101(9):547-553. doi: 10.1016/j.diii.2020.03.008. Epub 2020 Apr 3. PMID: 32253141.
- Park S, Joo I, Lee DH, Bae JS, Yoo J, Kim SW, Lee JM. Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI. Radiology. 2020 Sep;296(3):554-561. doi: 10.1148/radiol.2020192797. Epub 2020 Jul 21. PMID: 32692297.
- Seo N, Kim MS, Park MS, Choi JY, Do RKG, Han K, Kim MJ. Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017. Eur Radiol. 2020 Jan;30(1):261-271. doi: 10.1007/s00330-019-06376-5. Epub 2019 Aug 15. PMID: 31418085; PMCID: PMC7485122.
- Kim SW, Joo I, Kim HC, Ahn SJ, Kang HJ, Jeon SK, Lee JM. LI-RADS treatment response categorization on gadoxetic acid-enhanced MRI: diagnostic performance compared to mRECIST and added value of ancillary features. Eur Radiol. 2020 May;30(5):2861-2870. doi: 10.1007/s00330-019-06623-9. Epub 2020 Jan 31. PMID: 32006170.
- Ormiston WEL, Yarmohammadi H, Lobaugh S, Schilsky J, Katz SS, LaGratta M, Velayati S, Zheng J, Capanu M, Do RKG. Post-treatment CT LI-RADS categories: predictors of overall survival in hepatocellular carcinoma post bland transarterial embolization. Abdom Radiol (NY). 2020 Sep 24. doi: 10.1007/s00261-020-02775-1. Epub ahead of print. PMID: 32968863.
- Delli Pizzi A, Mastrodicasa D, Cianci R, Serafini FL, Mincuzzi E, Di Fabio F, Giammarino A, Mannetta G, Basilico R, Caulo M. Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice. Can Assoc Radiol J. 2020 May 21:846537120923982. doi: 10.1177/0846537120923982. Epub ahead of print. PMID: 32436394.
- Mendiratta-Lala M, Masch W, Shampain K, Zhang A, Jo A, Moorman A, Aslam A, Davenport M. MRI assessment of hepatocellular carcinoma after locoregional therapy: a comprehensive review. Radiology Cancer Imaging, 2020; 2(1): https://doi.org/10.1148/rycan.2020190024
Social Media is coordinated by Rony Kampalath: firstname.lastname@example.org
Twitter Account and Handle: SAR HCC Treatment Response DFP/ @HccResponseDFP
- Templates and Imaging Protocols
- Links for patients
SAR Liver Fibrosis DFP
To promote understanding and research in the common yet misunderstood disease of liver fibrosis.
- To educate practicing radiologists on the disease process, precursors (such as viral hepatitis, hemochromatosis, and steatohepatitis), and technique and value of imaging staging of liver fibrosis.
- To create a uniform reporting system and terminology in collaboration with hepatologists.
- To promote the development and use of imaging techniques for the diagnosis and monitoring of liver fibrosis. Imaging tests include US elastography/ARFI, MR elastography, diffusion and perfusion imaging, and CT.
- To develop guidelines for optimal early diagnosis, management and follow up of patients along the spectrum of disease. Guidelines will be informed by a respected multi-disciplinary team of radiologists, hepatologists and pathologists and account for variabilities in practice and resources among different facilities. Guidelines will include acceptable cut-off values and ranges for quantitative imaging techniques.
- To advance research of imaging techniques in an inter-disciplinary and multi-institutional manner to perform prospective and retrospective studies of imaging techniques.
- To define the role of imaging in the early diagnosis and follow-up of liver fibrosis. Evaluation will consider the wide use of serum fibrosis panels (including APRI, FIB4, Fibrotest, and PGA) and newer potential markers for NASH and the practical use of imaging tests in daily practice.
- To promote patient education about the importance of early diagnosis and follow-up of fibrosis and its precursors.
- To promote referring clinician education regarding available imaging methods for fibrosis for both diagnosis and monitoring.
SAR Liver Fibrosis DFP Members :
Richard Barr, MD, Northeast Ohio Medical University
Richard L. Ehman, MD, Mayo Clinic, Rochester, MN
Jonathan Dillman, MD, Cincinnati Children’s Hospital Medical Center
Flavius Guglielmo, MD, Thomas Jefferson University Hospital
Jeanne Horowitz, MD, Northwestern University
Karthik Jhaveri, MD, University of Toronto
James T. Lee, MD, University of Kentucky
Frank Miller, MD, Northwestern University
Roshan Y. Modi, MD, Christiana Care
Michael Ohlinger, MD, PhD, University of California San Francisco
Arinc Ozturk, MD, Massachusetts General Hospital
Teddy Pierce, MD from Massachusetts General Hospital
Anthony E. Samir, MD, MPH, Massachusetts General Hospital
Krishna Shanbhogue, MD, New York University
Alvin C. Silva, MD, Mayo Clinic, Arizona
Venkateswar Surabhi, MD, University of Texas at Houston
Bachir Taouli, MD, Icahn School of Medicine at Mount Sinai
Sudhakar Venkatesh, MD, Mayo Clinic, Rochester, MN
Christopher L. Welle, MD from Mayo Clinic, Rochester
Kwun Wen, MD PhD from University of California San Francisco
Benjamin M. Yeh, MD, University of California San Francisco
Hepatologist: Michael Torbenson, MD; Torbenson.Michael@mayo.edu
Pathologist: Patrick Kamath, MD; Kamath.Patrick@mayo.edu
Benjamin M. Yeh, MD
Prior Liver Fibrosis DFP Leadership:
Sudhakar Venkatesh, MD, Mayo Clinic. Chair, 2017-2020
Frank Miller, MD, Northwestern University. Chair, 2014-2017
Founding Members: Frank Miller, MD; Sudhakar Venkatesh, MD; Benjamin M Yeh, MD
- NEW! March 2021: Diffuse Liver Disease MR Imaging Hands-On Workshop– a combined workshop by the Liver Fibrosis DFP and the Liver Iron Overload DFP at the SAR Annual Meeting in Hollywood, Florida. A new Hands-On Workshop Resource Document will be available for all meeting attendees and will be posted here soon.
Liver Fibrosis DFP Recent Activities
- Initiated multi-institutional test of reproducibility of 3D MR Elastography in a phantom
- Retrospective study of fECS CT and MRI for quantification of liver fibrosis at Mayo Rochester UCSF – Manuscript in preparation and will be submitted to Abdominal Radiology
- Initiation of social media page
- Liver Fibrosis DFP Twitter Page – @Liver_Fibrosis
- Imaging techniques for liver fibrosis- One Page Summary:
- Magnetic Resonance Elastography (MRE)
- Measuring Liver Stiffness on Magnetic Resonance Elastography (MRE)
- Point Shear Wave Elastography (pSWE)
- 2D Shear Wave Elastography (2D-SWE)
- Vibration Controlled Transient Elastography (VCTE)
- Texture Analysis (TA)
- Diffusion Weighted Imaging (DWI)
- CT Liver Surface Nodularity
- Liver Fibrosis Article Database – Click here to reach the Liver Fibrosis Article Database to search through top articles selected by the Liver Fibrosis DFP.
- Liver Fibrosis Imaging Active 2020 Clinical Trials (clinicaltrials.gov)
Condition or Disease
Macromolecular proton fraction
Fibroscan, MRE, SWE, MRI-PDFF
Liver fibrosis, Cirrhosis, NASH
|NCT03436550||Portal hypertension||186||mpMRI, ARFI US|
- Liver fibrosis imaging dictation templates created by members of the SAR Liver Fibrosis DFP and Hepatic Iron Overload DFP (work in progress).
- MR Elastography, MR Fat Quantification and MR Iron Quantification Dictation Template
- US Elastography Dictation Template
Liver Fibrosis DFP Publications
- MR Elastography
- Guglielmo FF, Venkatesh SK, Mitchell DG. Liver MR Elastography Technique and Image Interpretation: Pearls and Pitfalls. Radiographics 2019;39(7):1983-2002.
- Srinivasa Babu A, Wells ML, Teytelboym OM, et al. Elastography in chronic liver disease: modalities, techniques, limitations, and future directions. Radiographics 2016;36(7):1987-2006.
- Venkatesh SK, Ehman RL. Magnetic resonance elastography of liver. MRI Clinics of NA 2014;22(3):433-446.
- Venkatesh SK, Wells ML, Miller FH, et al. Magnetic resonance elastography: beyond liver fibrosis—a case-based pictorial review. Abdom Radiology 2018;43(7):1590-1611.
- Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: clinical applications. JCAT 2013;37(6):887-896.
- Venkatesh SK, Yin M, Ehman RL. Magnetic resonance elastography of liver: technique, analysis, and clinical applications. JMRI 2013;37(3):544-555.
- Zhang YN, Fowler KJ, Ozturk A, Potu CK, Louie AL, Montes V, Henderson WC, Wang K, Andre MP, Samir AE, Sirlin CB. Liver fibrosis imaging: A clinical review of ultrasound and magnetic resonance elastography. J Magn Reson Imaging. 2020 Jan;51(1):25-42. doi: 10.1002/jmri.26716. Epub 2019 Mar 12. PMID: 30859677; PMCID: PMC6742585.
- Idilman IS, Li J, Yin M, Venkatesh SK. MR elastography of liver: current status and future perspectives. Abdom Radiol (NY). 2020 Jul 23. doi: 10.1007/s00261-020-02656-7. Epub ahead of print. PMID: 32705312.
- Li J, Venkatesh SK, Yin M. Advances in Magnetic Resonance Elastography of Liver. Magn Reson Imaging Clin N Am. 2020 Aug;28(3):331-340. doi: 10.1016/j.mric.2020.03.001. Epub 2020 Jun 6. PMID: 32624152; PMCID: PMC7338597.
- Allen AM, Shah VH, Therneau TM, Venkatesh SK, Mounajjed T, Larson JJ, Mara KC, Schulte PJ, Kellogg TA, Kendrick ML, McKenzie TJ, Greiner SM, Li J, Glaser KJ, Wells ML, Chen J, Ehman RL, Yin M. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery. Hepatology. 2020 Feb;71(2):510-521. doi: 10.1002/hep.30483. Epub 2019 Mar 15. PMID: 30582669; PMCID: PMC6591099.
- US Elastography
- Barr RG, Wilson SR, Rubens D, et al. Update to the Society of Radiologists in Ultrasound Liver Elastography Consensus Statement. Radiology 2020 296:2, 263-274
- Barr RG, Ferraioli G, Palmeri ML, et al. Elastography assessment of liver fibrosis: society of radiologists in ultrasound consensus conference statement. Radiology 2015;276(3):845-861.
- Kennedy P, Wagner M, Castéra L, et al. Quantitative elastography methods in liver disease: current evidence and future directions. Radiology 2018;286(3):738-763.
- Brattain LJ, Ozturk A, Telfer BA, Dhyani M, Grajo JR, Samir AE. Image Processing Pipeline for Liver Fibrosis Classification Using Ultrasound Shear Wave Elastography. Ultrasound Med Biol. 2020 Oct;46(10):2667-2676. doi: 10.1016/j.ultrasmedbio.2020.05.016. Epub 2020 Jul 2. PMID: 32622685; PMCID: PMC7483774.
- Ozturk A, Mohammadi R, Pierce TT, Kamarthi S, Dhyani M, Grajo JR, Corey KE, Chung RT, Bhan AK, Chhatwal J, Samir AE. Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease. Ultrasound Med Biol. 2020 Apr;46(4):972-980. doi: 10.1016/j.ultrasmedbio.2019.12.020. Epub 2020 Jan 29. PMID: 32005510; PMCID: PMC7034057.
- Ferraioli G, Barr RG, Dillman JR. Elastography for Pediatric Chronic Liver Disease: A Review and Expert Opinion . J Ultrasound Med. 2020 Sep 3. doi: 10.1002/jum.15482. Epub ahead of print. PMID: 32881048.
- Alhashmi GH, Gupta A, Trout AT, Dillman JR. Two-dimensional ultrasound shear wave elastography for identifying and staging liver fibrosis in pediatric patients with known or suspected liver disease: a clinical effectiveness study. Pediatr Radiol. 2020 Aug;50(9):1255-1262. doi: 10.1007/s00247-020-04720-2. Epub 2020 Jun 25. PMID: 32588095.
- Tafur M, Cheung A, Menezes RJ, Feld J, Janssen H, Hirschfield GM, Jhaveri KS. Risk stratification in primary sclerosing cholangitis: comparison of biliary stricture severity on MRCP versus liver stiffness by MR elastography and vibration-controlled transient elastography . Eur Radiol. 2020 Jul;30(7):3735-3747. doi: 10.1007/s00330-020-06728-6. Epub 2020 Mar 4. PMID: 32130494.
- Liver Fibrosis (General)
- Horowitz JM, Venkatesh SK, Ehman RL, et al. Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiology 2017;42(8):2037-2053.
- Kennedy P, Taouli B. Collagen-targeted MRI contrast agent for liver fibrosis detection. Nat Rev Gastroenterol Hepatol. 2020 Apr;17(4):201-202. doi: 10.1038/s41575-020-0266-z. PMID: 31980755.
- Taouli B, Alves FC. Imaging biomarkers of diffuse liver disease: current status. Abdom Radiol (NY). 2020 Jun 25. doi: 10.1007/s00261-020-02619-y. Epub ahead of print. PMID: 32583139.
Fatty Liver Disease and Liver Fibrosis
Cirrhosis of the Liver
To facilitate earlier diagnosis, better understanding of the pathophysiology, biological behavior and natural history, stratify prognosis, improve assessment of treatment response and impact the survival and morbidity of the abdominopelvic neuroendocrine tumors by augmenting interdisciplinary collaboration, knowledge and research within the radiology community by utilizing conventional and emerging imaging techniques.
Increase interdisciplinary and multi-institutional collaborations by:
- Forming a nonbiased committee represented by multiple institutions and medical specialties that truly reflects the greater neuroendocrine community.
- Creating resources for the society
- Case of the months and Annual (or more frequent) face to face or web based meetings among the DFP members to facilitate implementation of ongoing plans and activities, and explore new ideas towards education and research of the abdominopelvic (AP) neuroendocrine tumors.
- Interdisciplinary collaborations to understand and update the knowledge in AP NETs.
- Drawing on the expertise of its members from participation in societies dedicated to the mission of AP NETs.
Educate the panel members, and ultimately the society as a whole, of the topics in AP NETs both within and outside of radiology through:
- Lectures at the annual meetings from the lead consultant and multi-institutional radiology and non-radiology expert consultants.
- Drawing on the knowledge of various specialists on our panel by lectures (e.g. WebEx, webinars) to the panel members regularly throughout the year, with the goal of ultimately spreading such information to the wider society.
- Review articles by panel members to allow for wider and more accessible dissemination of knowledge.
- Develop research topics and conduct original studies wholly within radiology as well as integrated into multidisciplinary efforts of larger scope projects on AP NETs.
- Integrate with the ongoing SAR project of developing a multi-institution platform for storing and reviewing images for the purposes of research projects.
Leadership and Membership:
Founding Chairs: Priya Bhosale, MD and Ajaykumar Morani, MD
Chair: Priya Bhosale, MD
Co-chair 1: Ajaykumar Morani, MD
Co-chair 2: Motoyo Yano, MD
Co-chair 3: Chandana Lall, MD
Co-chair 4: Sadhna Verma MD
Chairs in succession:
Ajaykumar Morani, MD
Motoyo Yano, MD
Chandana Lall, MD
Sadhna Verma MD
Lead Oncology Consultant: Daniel Halperin, MD
Chair of GEP and other AP NET DFP: Priya Bhosale MD
Chair of GI Neuroendocrine Tumors: Ajaykumar Morani, MD
Chair of Pancreatic Neuroendocrine Tumors: Motoyo Yano, MD, PhD
Chair and Co-chair of other AP Neuroendocrine Tumors – Chandana Lall, MD (Chair) and Sadhna Verma MD (Co-Chair)
Director of Education for Case of the Month for the DFP: Dr. Reddy, MD MBA
Director of Protocol and Template Management: Malak Itani, MD and Amir Iravani, MD
Priya Bhosale, MD (Co-Chair)
Ajaykumar C Morani, MD (Co-chair)
Motoyo Yano, MD (Chair of Pancreatic Neuroendocrine Tumors)
Chandana Lall, MD (Co-chair of other AP Neuroendocrine Tumors)
Sadhana Verma, MD (Co-chair of other AP Neuroendocrine Tumors)
Malak Itani MD (Director of Protocol and Template Management)
Dheeraj R Gopireddy, MD (Director of Education for Case of the Month)
Amir Iravani, MD (Director of Protocol and Template Management)
Isaac Francis, MD
Kedar G Sharbidre, MD
Juan Ibbara, MD
Samuel Galgano, MD
Sanaz Javadi, MD
John Millet, MD, MHS
Manohar Roda, MD
Ajit Goenka, MD
Thomas Hope, MD
Silvana Faria, MD
Michael Blake, MD
Heather Jacene, MD
David Bates MD
Beth Chasen, MD
Hina Arif, MD
Smita Sharma, MD
Daniel Halperin, MD (Chief consultant)
Mathew Katz, MD
Ching-Wei David Tzeng, MD
Emily Bergsland, MD
Palmela Kunz, MD
Manoop Bhutani, MD
Michael Frumovitz MD
Huamin Wang, MD
Koushik Das, MD
Deyali Chatterjee, MD
Nikolaos Trikalinos, MD
Hyun Kim, MD
Chet Hammill, MD
Jessica Maxwell, MD
- Bi-monthly education web lectures in the DFP meetings
- Case of the month uploaded by DFP members every month
- Working on optimizing imaging protocols for NET
- Working on unified template for NET reporting
- Creating survey for oncologists, surgeons and radiologists on current practices for imaging and reporting NETs
- Collaboration with other neuroendocrine and related societies
- North American Neuroendocrine Tumor Society annual meeting (Oct 2-3, 2020)
- Neuroendocrine Tumor Research Foundation (NETRFF) Symposium (Nov 19-20, 2020)
- European Neuroendocrine Tumor Society annual conference (Feb 25-27, 2021)
- Society of Abdominal Radiology annual meeting (March 21-24, 2021)
- Goncalves I, Burbury K, Michael M, Iravani A, Ravi Kumar AS, Akhurst T, Tiong IS, Blombery P, Hofman MS, Westerman D, Hicks RJ, Kong G 2019 Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series. European journal of nuclear medicine and molecular imaging 46:1902-1910. https://doi.org/10.1007/s00259-019-04389-2. https://www.ncbi.nlm.nih.gov/pubmed/31187162.
- Kong G, Schenberg T, Yates CJ, Trainer A, Sachithanandan N, Iravani A, Ravi Kumar A, Hofman MS, Akhurst T, Michael M, Hicks RJ 2019 The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma. The Journal of clinical endocrinology and metabolism 104:5091-5099. https://doi.org/10.1210/jc.2019-00018. https://www.ncbi.nlm.nih.gov/pubmed/30977831.
- Zidan L, Iravani A, Kong G, Akhurst T, Michael M, Hicks RJ. Theranostic implications of molecular imaging phenotype of well-differentiated pulmonary carcinoid based on 68Ga-DOTATATE PET/CT and 18F-FDG PET/CT. Eur J Nucl Med Mol Imaging. 2020. PMID:32572559
- Priya Bhosale, Jin Wei Kwek, Revathy Iyer, Wei Wei, Roland Bassett, Vikas Kundra. Follow-up of known carcinoid liver metastases: is respiratory-gated t(2) fast spin-echo enough? Neuroendocrinology. 2011;93(4):241-8. doi: 10.1159/000326237. Epub 2011 Apr 7. https://pubmed.ncbi.nlm.nih.gov/21474918/
- Gustavo Felipe Luersen, W Wei, Eric P Tamm, Priya R Bhosale, Janio Szklaruk. Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration. J Comput Assist Tomogr. Sep-Oct 2016;40(5):717-22. doi: 10.1097/RCT.0000000000000425. https://pubmed.ncbi.nlm.nih.gov/27636124/
- Imaging and staging of neuroendocrine cervical cancer. Elsherif S, Odisio EGLC, Faria S, Javadi S, Yedururi S, Frumovitz M, Ramalingam P, Bhosale P. Abdom Radiol (NY). 2018 Dec;43(12):3468-3478. doi: 10.1007/s00261-018-1667-0. PMID: 29974177 Review.
- State-of-the-art Imaging of Pancreatic Neuroendocrine Tumors. Tamm EP, Bhosale P, Lee JH, Rohren EM. Surg Oncol Clin N Am. 2016 Apr;25(2):375-400. doi: 10.1016/j.soc.2015.11.007. PMID: 27013371 Free PMC article. Review.
- Pancreatic neuroendocrine neoplasms: diagnosis and management. Balachandran A, Tamm EP, Bhosale PR, Patnana M, Vikram R, Fleming JB, Katz MH, Charnsangavej C. Abdom Imaging. 2013 Apr;38(2):342-57. doi: 10.1007/s00261-012-9923-1. PMID: 22707246
- Imaging of pancreatic neoplasms. Balachandran A, Bhosale PR, Charnsangavej C, Tamm EP. Surg Oncol Clin N Am. 2014 Oct;23(4):751-88. doi: 10.1016/j.soc.2014.07.002. PMID: 25246049 Review.
- Cross sectional and nuclear medicine imaging of pancreatic insulinomas. Rayamajhi SJ, Lee J, Mittal BR, Jessop AC, Chasen B, Bhosale P. Abdom Radiol (NY). 2017 Feb;42(2):531-543. doi: 10.1007/s00261-016-0904-7. PMID: 27639564 Review.
- Venous tumor thrombus in nonfunctional pancreatic neuroendocrine tumors. Balachandran A, Tamm EP, Bhosale PR, Katz MH, Fleming JB, Yao JC, Charnsangavej C. AJR Am J Roentgenol. 2012 Sep;199(3):602-8. doi: 10.2214/AJR.11.7058. PMID: 22915400
- Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors. Prakash L, Bhosale P, Cloyd J, Kim M, Parker N, Yao J, Dasari A, Halperin D, Aloia T, Lee JE, Vauthey JN, Fleming JB, Katz MH. J Gastrointest Surg. 2017 Jan;21(1):155-163. doi: 10.1007/s11605-016-3270-4. Epub 2016 Sep 15. PMID: 27634306
- Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation. Bhosale PR, Menias CO, Balachandran A, Tamm EP, Charnsangavej C, Francis IR, Elsayes KM. Abdom Imaging. 2013 Aug;38(4):802-17. doi: 10.1007/s00261-012-9954-7. PMID: 22968429 Review.
- Evaluation of Magnetic Resonance (MR) Biomarkers for Assessment of Response With Response Evaluation Criteria in Solid Tumors: Comparison of the Measurements of Neuroendocrine Tumor Liver Metastases (NETLM) With Various MR Sequences and at Multiple Phases of Contrast Administration. Luersen GF, Wei W, Tamm EP, Bhosale PR, Szklaruk J. J Comput Assist Tomogr. 2016 Sep-Oct;40(5):717-22. doi: 10.1097/RCT.0000000000000425. PMID: 27636124 Free PMC article.
- Role and Operative Technique of Portal Venous Tumor Thrombectomy in Patients with Pancreatic Neuroendocrine Tumors. Prakash L, Lee JE, Yao J, Bhosale P, Balachandran A, Wang H, Fleming JB, Katz MH. J Gastrointest Surg. 2015 Nov;19(11):2011-8. doi: 10.1007/s11605-015-2914-0. Epub 2015 Aug 18. PMID: 26282850
- Pancreatic Neuroendocrine Tumors: Computed Tomography Enhancement, But Not Histological Grade, Correlates With Tumor Aggression. Yano M, Misra S, Carpenter DH, Salter A, Hildebolt CF.Pancreas. 2017 Nov/Dec;46(10):1366-1372. doi: 10.1097/MPA.0000000000000922.PMID: 28930867
- Assessment of disease aggression in cystic pancreatic neuroendocrine tumors: A CT and pathology correlation study. Yano M, Misra S, Salter A, Carpenter DH.Pancreatology. 2017 Jul-Aug;17(4):605-610. doi: 10.1016/j.pan.2017.05.388. Epub 2017 May 27.PMID: 28619284
- Tumor evolution in a patient with recurrent endometrial cancer and synchronous neuroendocrine cancer and response to checkpoint inhibitor treatment. Trikalinos NA, Chatterjee D, Winter K, Powell M, Yano M.Oncologist. 2020 Sep 18. doi: 10.1002/onco.13525. Online ahead of print.PMID: 32945065
- Imaging features of adrenal gland masses in the pediatric population. Hanafy AK, Mujtaba B, Roman-Colon AM, Elsayes KM, Harrison D, Ramani NS, Waguespack SG, Morani AC. Abdom Radiol (NY). 2020 Apr;45(4):964-981. doi: 10.1007/s00261-019-02213-x. PMID: 31538225
- Practical Approach to Adrenal Imaging. Elsayes KM, Emad-Eldin S, Morani AC, Jensen CT. Urol Clin North Am. 2018 Aug;45(3):365-387. doi: 10.1016/j.ucl.2018.03.005. PMID: 30031460
- Practical Approach to Adrenal Imaging. Elsayes KM, Emad-Eldin S, Morani AC, Jensen CT. Radiol Clin North Am. 2017 Mar;55(2):279-301. doi: 10.1016/j.rcl.2016.10.005. Epub 2016 Dec 12. PMID: 28126216
- Mimics, pitfalls, and misdiagnoses of adrenal masses on CT and MRI. Elsayes KM, Elmohr MM, Javadi S, Menias CO, Remer EM, Morani AC, Shaaban AM. Abdom Radiol (NY). 2020 Apr;45(4):982-1000. doi: 10.1007/s00261-019-02082-4. PMID: 31165195
- Multiple Endocrine Neoplasia: Spectrum of Abdominal Manifestations. Davila A, Menias CO, Alhalabi K, Lall C, Pickhardt PJ, Lubner M, Elsayes KM. AJR Am J Roentgenol. 2020 Oct;215(4):885-895. doi: 10.2214/AJR.19.22542. Epub 2020 Jul 13. PMID: 32755185
- Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Salvo G, Gonzalez Martin A, Gonzales NR, Frumovitz M. Int J Gynecol Cancer. 2019 Jul;29(6):986-995. doi: 10.1136/ijgc-2019-000504. PMID: 31263021.
- Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix. Carroll MR, Ramalingam P, Salvo G, Fujimoto J, Solis Soto LM, Phoolcharoen N, Hillman RT, Cardnell R, Byers L, Frumovitz M. Int J Gynecol Cancer. 2020 Sep;30(9):1303-1307. doi: 10.1136/ijgc-2020-001649. Epub 2020 Jul 29. PMID: 32727929.
- Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract. Frumovitz M, Westin SN, Salvo G, Zarifa A, Xu M, Yap TA, Rodon AJ, Karp DD, Abonofal A, Jazaeri AA, Naing A. Gynecol Oncol. 2020 Sep;158(3):570-575. doi: 10.1016/j.ygyno.2020.05.682. Epub 2020 Jun 11. PMID: 32534809; PMCID: PMC7486997.
- Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. Frumovitz M, Munsell MF, Burzawa JK, Byers LA, Ramalingam P, Brown J, Coleman RL. Gynecol Oncol. 2017 Jan;144(1):46-50. Doi: 10.1016/j.ygyno.2016.10.040. Epub 2016 Nov 4. PMID: 27823771; PMCID: PMC5873577.
https://www.facebook.com/groups/scccsisters (cervical neuroendocrine support group)
Templates and Imaging Protocols
Works in progress
Links for patients
- American Pancreatic Association
- Lustgarten Foundation: Pancreatic Cancer Research https://lustgarten.org/
- Neuroendocrine Tumor Research Foundation (NETRF) https://netrf.org/for-patients/
- The North American Neuroendocrine Tumor Society (NANETS) https://nanets.net/
- Society of Nuclear Medicine & Molecular Imaging (SNMMI) http://www.snmmi.org/Patients/
- European Neuroendocrine Tumor Society (ENETS) https://www.enets.org
- National Comprehensive Cancer Network (NCCN) https://www.nccn.org
The mission of Pancreatitis DFP is to educate, disseminate, and advance the role of imaging in the diagnosis and management of patients with pancreatitis.
Twitter: @PancreatitisDFP https://twitter.com/PancreatitisDFP
Teaching Atlas of Pancreatitis
Temel Tirkes, MD, FACR; Associate Professor of Radiology and Imaging Sciences
Bhavik N. Patel, MD, MBA; Assistant Professor of Radiology; Stanford University
Atif Zaheer, MD; Associate Professor of Radiology; Johns Hopkins University
Kumar Sandrasegaran, MD; Professor of Radiology; Mayo Clinic, Scottsdale
Desiree E. Morgan, MD; Professor of Radiology; University of Alabama Medical School
Frank Miller, MD; Professor of Radiology; Northwestern University
R. Brooke Jeffrey, MD; Professor of Radiology; Stanford University
Fatih Akisik, MD; Professor of Clinical Radiology; Indiana University
Dushyant Sahani, MD; Professor of Radiology; Washington University
Peter Poullos, MD; Clinical Associate Professor of Radiology; Stanford University Medical Center
Pardeep Mittal, MD; Associate Professor of Radiology; Emory University
Jordan K Swensson, MD; Assistant Professor of Clinical Radiology; Indiana University
Anil K Dasyam, MD; Associate Professor of Radiology; University of Pittsburgh Medical Center
Abraham Fourie Bezuidenhout, MD; BIDMC – HMFP Radiology
Alan J. Cubre, MD; Assistant Professor; Brigham and Women’s Hospital
Zarine Shah, MD; Assistant Professor; Ohio State University
- Dhiraj Yadav, MD; Professor of Medicine; University of Pittsburgh Medical Center; email@example.com
- Darwin L Conwell, MD; Professor of Medicine, Ohio State University; firstname.lastname@example.org
- Walter Park, MD; Associate Professor of Medicine, Stanford; email@example.com
Temel Tirkes, MD, FACR
Associate Professor of Radiology and Imaging Sciences
Indiana University School of Medicine
- Creating educational materials on pancreatitis and online disseminating via the DFP website.
- Investigate possible imaging biomarkers that can be used for severity and monitoring the course of chronic pancreatitis during investigational therapies
- Create a consensus on indications of secretin for MRCP
- Determine the association between the pancreatic size/volume with chronic pancreatitis and T2DM.
- Create educational materials on pancreatitis to be presented on the DFP website.
- Lead: Abraham Bezuidenhout, MD
- Rationale: There is a need for a collection of most up to date teaching materials for trainees in radiology. We are aiming to disseminate the most up to date information via online material
- Deliverables: Teaching materials on pancreatitis
- Timeline: 1 year
- Investigate possible imaging biomarkers that can be used for severity and monitoring the course of chronic pancreatitis during investigational therapies
- Lead: Temel Tirkes, MD
- Consultants: Dhiraj Yadav, MD; Darwin L Conwell, MD
- Rationale: Characteristic features of CP may be absent on standard imaging studies. Preliminary data suggest that quantitative features on MRI not currently used in clinical practice (T1 relaxation time, extracellular volume fraction, T1-weighted gradient-echo signal intensity ratio, diffusion-weighted imaging) can be useful for the diagnosis of CP. However, limited data exist in healthy subjects or those with CP.
- One of the objectives yet to be completed by the pancreas radiologists is to detect and quantify pancreatic fibrosis. In this multi-institutional study, we aim to show that MRI can serve as a valuable non- invasive biomarker to identify and grade CP. The NIDDK funded this multi-institutional study (MINIMAP; PMID: 31089778). We will combine the results from the primary and secondary endpoints to generate a composite scoring system to be used in clinical practice as well as clinical trials.
- Timeline: 3 years
- Secretin Enhanced MRCP: When & How
This is an invited expert panel review invitation from incoming AJR GI Section Editor, Dr. Miller.
- Lead: Jordan Swensson, MD
- Consultant: Darwin L Conwell, MD
- Rationale Consensus among the radiologists about indications and imaging techniques for secretin. Address issues around when secretin is necessary and which patients will benefit. How to prescribe and perform secretin enhanced MRCP?
- Timeline: 1 year
- Determine the association between the pancreatic volume and size with chronic pancreatitis and type 2 DM.
- Lead: Temel Tirkes, MD
- Consultant: Dhiraj Yadav, MD
- Rationale: There is no sufficient data on pancreatic volume and diameter in patients with chronic pancreatitis and type 2 diabetes. We aim to investigate the correlation of pancreatic size and volume with chronic pancreatitis and type 2 diabetes.
- Timeline: 3 years
Reporting of acute pancreatitis by radiologists-time for a systematic change with structured reporting template.
Khurana A, Nelson LW, Myers CB, et al. Abdom Radiol (NY). 2020;45(5):1277-1289. https://doi.org/10.1148/radiol.2018181353
Reporting Standards for Chronic Pancreatitis by Using CT, MRI, and MR Cholangiopancreatography: The Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer.
Tirkes T, Shah ZK, Takahashi N, et al. Radiology. 2019;290(1):207-215.
Volume 45, issue 5, May 2020
Special Section on Pancreatitis
MRI in acute pancreatitis.
Sandrasegaran, K., Heller, M.T., Panda, A. et al. Abdom Radiol45, 1232–1242 (2020). https://doi.org/10.1007/s00261-019-02141-w
Advanced imaging techniques for chronic pancreatitis.
Parakh, A., Tirkes, T. Abdom Radiol 45, 1420–1438 (2020). https://doi.org/10.1007/s00261-019-02191-0
Emerging imaging techniques for acute pancreatitis.
Ghandili, S., Shayesteh, S., Fouladi, D.F. et al. Abdom Radiol 45, 1299–1307 (2020). https://doi.org/10.1007/s00261-019-02192-z
Acute pancreatitis: an update on the revised Atlanta classification.
Colvin, S.D., Smith, E.N., Morgan, D.E. et al. Abdom Radiol 45, 1222–1231 (2020). https://doi.org/10.1007/s00261-019-02214-w
CT imaging, classification, and complications of acute pancreatitis.
Fung, C., Svystun, O., Fouladi, D.F. et al. Abdom Radiol 45, 1243–1252 (2020). https://doi.org/10.1007/s00261-019-02236-4
Utility of ultrasound in acute pancreatitis.
Burrowes, D.P., Choi, H.H., Rodgers, S.K. et al. Abdom Radiol 45, 1253–1264 (2020). https://doi.org/10.1007/s00261-019-02364-x
Sharbidre, K.G., Galgano, S.J. & Morgan, D.E. Abdom Radiol 45, 1265–1276 (2020). https://doi.org/10.1007/s00261-019-02241-7
Initial experience with 3D CT cinematic rendering of acute pancreatitis and associated complications.
Rowe, S.P., Chu, L.C. & Fishman, E.K. Abdom Radiol 45, 1290–1298 (2020). https://doi.org/10.1007/s00261-019-02310-x
Endoscopic intervention in pancreatitis: perspectives from a gastroenterologist.
Gurakar, M., Faghih, M. & Singh, V.K. Abdom Radiol 45, 1308–1315 (2020). https://doi.org/10.1007/s00261-019-02314-7
Pancreatitis in the developmentally anomalous pancreas.
Wood, C.G., Lopes Vendrami, C., Craig, E. et al. Abdom Radiol 45, 1316–1323 (2020). https://doi.org/10.1007/s00261-019-02197-8
Pancreatitis and PDAC: association and differentiation.
Elsherif, S.B., Virarkar, M., Javadi, S. et al. Abdom Radiol 45, 1324–1337 (2020). https://doi.org/10.1007/s00261-019-02292-w
Imaging guidelines for acute pancreatitis: when and when not to image.
Rocha, A.P.C., Schawkat, K. & Mortele, K.J. Abdom Radiol 45, 1338–1349 (2020). https://doi.org/10.1007/s00261-019-02319-2
Fat-modified computed tomography severity index (CTSI) is a better predictor of severity and outcome in patients with acute pancreatitis compared with modified CTSI.
Gupta, P., Dawra, S., Chandel, K. et al. Abdom Radiol 45, 1350–1358 (2020). https://doi.org/10.1007/s00261-020-02473-y
Autoimmune pancreatitis: an update.
Khandelwal, A., Inoue, D. & Takahashi, N. Abdom Radiol 45, 1359–1370 (2020). https://doi.org/10.1007/s00261-019-02275-x
Differentiation of focal autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lopes Vendrami, C., Shin, J.S., Hammond, N.A. et al. Abdom Radiol 45, 1371–1386 (2020). https://doi.org/10.1007/s00261-019-02210-0
Endoscopic and surgical treatment options for chronic pancreatitis: an imaging perspective.
Shanbhogue, K., Pourvaziri, A., Jeyaraj, S.K. et al. Abdom Radiol 45, 1397–1409 (2020). https://doi.org/10.1007/s00261-019-02249-z
Optimum imaging of chronic pancreatitis.
Zamboni, G.A., Ambrosetti, M.C., Pezzullo, M. et al. Abdom Radiol 45, 1410–1419 (2020). https://doi.org/10.1007/s00261-020-02492-9
Groove pancreatitis: a clinical and imaging overview.
Patel, B.N., Brooke Jeffrey, R., Olcott, E.W. et al. Abdom Radiol 45, 1439–1446 (2020). https://doi.org/10.1007/s00261-019-02239-1
Cross-sectional imaging-based severity scoring of chronic pancreatitis: why it is necessary and how it can be done.
Dasyam, A.K., Shah, Z.K., Tirkes, T. et al. Abdom Radiol 45, 1447–1457 (2020). https://doi.org/10.1007/s00261-019-02218-6
Value of multidisciplinary collaboration in acute and chronic pancreatitis.
Haj-Mirzaian, A., Patel, B.N., Fishman, E.K. et al. Abdom Radiol 45, 1458–1467 (2020). https://doi.org/10.1007/s00261-019-02320-9
Inter-observer variability of radiologists for Cambridge classification of chronic pancreatitis using CT and MRCP: results from a large multi-center study.
Tirkes, T., Shah, Z.K., Takahashi, N. et al. Abdom Radiol 45, 1481–1487 (2020). https://doi.org/10.1007/s00261-020-02521-7
Impact of age on the diagnostic performance of pancreatic ductal diameters in detecting chronic pancreatitis.
Frøkjær, J.B., Olesen, S.S., Drewes, A.M. et al. Abdom Radiol 45, 1488–1494 (2020). https://doi.org/10.1007/s00261-020-02522-6
Ultrasonography in characterizing collections in acute pancreatitis.
Madhusudhan, K.S., Srivastava, D.N. Abdom Radiol 45, 1495–1496 (2020). https://doi.org/10.1007/s00261-020-02494-7
Role of extrapancreatic necrosis volume in determining early prognosis in patients with acute pancreatitis.
Çakar, İ., Keven, A., Eseroğlu, E. et al. Abdom Radiol 45, 1507–1516 (2020). https://doi.org/10.1007/s00261-019-02188-9
Radiation dose from computed tomography in patients with acute pancreatitis: an audit from a tertiary care referral hospital.
Gupta, P., Jain, R., Koshi, S. et al. Abdom Radiol 45, 1517–1523 (2020). https://doi.org/10.1007/s00261-020-02408-7
Diagnostic accuracy of unenhanced CT texture analysis to differentiate mass-forming pancreatitis from pancreatic ductal adenocarcinoma.
Ren, S., Zhao, R., Zhang, J. et al. Abdom Radiol 45, 1524–1533 (2020). https://doi.org/10.1007/s00261-020-02506-6
The augmented role of pancreatic imaging in the era of endoscopic necrosectomy: an illustrative and pictorial review.
Kapoor, H., Issa, M., Winkler, M.A. et al. Abdom Radiol 45, 1534–1549 (2020). https://doi.org/10.1007/s00261-019-02093-1
New, Informing or Interesting Publications
Normal T1 relaxometry and extracellular volume of the pancreas in subjects with no pancreas disease: correlation with age and gender.
Tirkes T, Mitchell JR, Li L, Zhao X, Lin C. Abdom Radiol (NY). 2019;44(9):3133-3138. doi:10.1007/s00261-019-02071-7
Evaluation of variable flip angle, MOLLI, SASHA, and IR-SNAPSHOT pulse sequences for T1 relaxometry and extracellular volume imaging of the pancreas and liver.
Tirkes T, Zhao X, Lin C, et al. MAGMA. 2019;32(5):559-566. doi:10.1007/s10334-019-00762-2
Quantitative MR Evaluation of Chronic Pancreatitis: Extracellular Volume Fraction and MR Relaxometry.
Tirkes T, Lin C, Cui E, et al. AJR Am J Roentgenol. 2018;210(3):533-542. doi:10.2214/AJR.17.18606
T1 mapping for diagnosis of mild chronic pancreatitis.
Tirkes T, Lin C, Fogel EL, Sherman SS, Wang Q, Sandrasegaran K. J Magn Reson Imaging. 2017;45(4):1171-1176. doi:10.1002/jmri.25428
Secretin-enhanced MR cholangiopancreatography: spectrum of findings.
Tirkes T, Sandrasegaran K, Sanyal R, et al. Radiographics. 2013;33(7):1889-1906. doi:10.1148/rg.337125014
MRCP in patient care: a prospective survey of gastroenterologists.
Akisik MF, Jennings SG, Aisen AM, et al. AJR Am J Roentgenol. 2013;201(3):573-577. doi:10.2214/AJR.12.9900
Association of Pancreatic Steatosis With Chronic Pancreatitis, Obesity, and Type 2 Diabetes Mellitus.
Tirkes T, Jeon CY, Li L, et al. Pancreas. 2019;48(3):420-426. doi:10.1097/MPA.0000000000001252
PROPOSED CONTRIBUTIONS TO SAR EDUCATION PROGRAM:
- Review article and/or workshop at the SAR on guidelines for appropriate imaging for pancreatitis (i.e., modality, protocols standards, frequency)
- Scientific paper(s) on imaging predictors of severity of pancreatitis and outcomes
- Series of workshops and plenary at the SAR focused on imaged based classification of pancreatitis, the role of imaging in diagnosis and management of all forms of pancreatitis, the role of percutaneous interventions in pancreatitis associated fluid collections, and management update of all forms of pancreatitis (surgical and medical perspective)
To improve the care of patients with pancreatic cancer through imaging with initiatives to improve communication between radiology and other clinical specialties, and to perform research and facilitate implementation of best practices for the detection, diagnosis, staging, and monitoring of treatment response for this disease.
The educational objectives of the panel include discussion of conventional radiology topics such as current best practices for imaging of pancreatic cancer comprising of CT, MRI and PET/CT and the incorporation of technologies such as endoscopic ultrasound into the workflow of diagnosing and staging pancreatic cancer. The role of imaging in clinically pertinent areas such as identification of recurrence, monitoring of treatment response and management of complications of treatment will be also be discussed. The short term educational goals would be accomplished through a combination of educational initiatives as outlined below:
- Lectures and/or workshops at the annual SAR meeting and review articles in Abdominal Radiology.
- Lectures/ workshops at other major radiology and non-radiology national conferences (SAR, RSNA, ISMRM, ARRS, ASCO, DDW).
- Regular webinars or WebEx lectures throughout the year (proposed goal – 4-6/year). The content of the webinars will expand on the scope of topics regularly delivered at the annual meeting. The format of the webinars would be structured as lectures and/or workshops that will aim to bring to the Society knowledge of the greater outer world of pancreatic cancer as experienced by our colleagues in surgical oncology, medical oncology, radiation oncology, and gastroenterology and the current state-of-the-art of research.
- Multi-center imaging trials/projects for further development of imaging and its role in pancreatic cancer. Our goal is for DFP members to select topics of interest, set up ground work (choosing project lead/PIs, submitting and getting approval of institutional IRB requests, etc.), determine feasibility, and initiate the research process.
- To assess the current state of knowledge with regard to biomarkers (see recent review article accepted for publication in Abdominal Radiology) and to potentially do research to identify pancreatic cancer imaging biomarkers.
- To study the value of imaging in the setting of neoadjuvant chemo-radiation in patients with borderline and locally advanced pancreatic cancer prior to surgical resection.
Zhen Jane Wang, MD (Co-Chair, Education)
Avinash Kambadakone (Co-Chair, Research)
Hina Arif, MD
Priya Bhosale, MD
Candice Bolan, MD
Olga Brook, MD
Richard Do, MD
Jason Fleming, MD, FACS
Samuel Galgano, MD
Ajit Goenka, MD
Alexander Guimares, MD, PhD
Elizabeth Hecht, MD
David Hough, MD
Naveen Kulkarni, MD
Ott Le, MD
Lyndon Luk, MD
Lorenzo Mannelli, MD
Michael Rosenthal, MD
Guillermo Sangster, MD
Zarine Shah, MD
Alison Sheridan, MD
Erik Soloff, MD
Eric Tamm, MD
Parag Tolat, MD
Atif Zaheer, MD
Marc Zins, MD
- Accepted for publication in Abdominal Radiology: “Therapeutic Response Assessment In Pancreatic Ductal Adenocarcinoma: Society Of Abdominal Radiology Review Paper On The Role of Morphological And Functional Imaging Techniques”
- The DFP is currently involved in developing a manuscript detailing postoperative pancreas management.
- 8/25: Gabi Chiorean, Professor of Medical Oncology from University of Washington
- The goal of the PDAC DFP Mentoring Program is to develop the next generation of SAR pancreatic cancer radiology experts and leaders. Our Mentoring Program is in its initial year of implementation and involves interested mentees paired with a mentor to develop a personalized program intended to meet goals and consideration for a position within the pancreas adenocarcinoma DFP.
The pancreas adenocarcinoma DFP supports multiple pancreatic cancer workshops at the SAR Annual Meeting that differ in subject and scope (https://www.abdominalradiology.org/page/MeetingsArchive). All future and upcoming workshops will be listed on this website as well as on the DFP Twitter and Instagram accounts.
A special issue of Abdominal Radiology led by this DFP focused on pancreatic cancer and was published in February 2018 (https://link.springer.com/journal/261/volumes-and-issues/43-2). The DFP publishes manuscripts annually, with recent publications as follows:
- Kulkarni NM, Mannelli L, Zins M, et al. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology’s disease-focused panel for pancreatic ductal adenocarcinoma: Part II, update on imaging techniques and screening of pancreatic cancer in high-risk individuals. Abdom Radiol (NY). 2020;45(3):729-42.
- Kulkarni NM, Soloff EV, Tolat PP, et al. White paper on pancreatic ductal adenocarcinoma from society of abdominal radiology’s disease-focused panel for pancreatic ductal adenocarcinoma: Part I, AJCC staging system, NCCN guidelines, and borderline resectable disease. Abdom Radiol (NY). 2020;45(3):716-28.
- Baliyan V, Kordbacheh H, Parakh A, Kambadakone A. Response assessment in pancreatic ductal adenocarcinoma: role of imaging. Abdom Radiol (NY). 2018;43(2):435-44.
- Bhalla M, Aldakkak M, Kulkarni NM, et al. Characterizing indeterminate liver lesions in patients with localized pancreatic cancer at the time of diagnosis. Abdom Radiol (NY). 2018;43(2):351-63.
- Bhattacharya A, Gandhi NS, Baker ME, Chahal P. Gastroenterology and pancreatic adenocarcinoma: what the radiologist needs to know. Abdom Radiol (NY). 2018;43(2):364-73.
- Bhosale P, Cox V, Faria S, et al. Genetics of pancreatic cancer and implications for therapy. Abdom Radiol (NY). 2018;43(2):404-14.
- Camacho A, Fang J, Cohen MP, Raptopoulos V, Brook OR. Split-bolus pancreas CTA protocol for local staging of pancreatic cancer and detection and characterization of liver lesions. Abdom Radiol (NY). 2018;43(2):340-50.
- Fogelman DR, Varadhachary G. Medical oncology and pancreatic cancer: what the radiologist needs to know. Abdom Radiol (NY). 2018;43(2):383-92.
- Fonseca AL, Fleming JB. Surgery for pancreatic cancer: critical radiologic findings for clinical decision making. Abdom Radiol (NY). 2018;43(2):374-82.
- Gandhi NS, Feldman MK, Le O, Morris-Stiff G. Imaging mimics of pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2018;43(2):273-84.
- Garces-Descovich A, Beker K, Jaramillo-Cardoso A, James Moser A, Mortele KJ. Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls. Abdom Radiol (NY). 2018;43(2):314-22.
- Hafezi-Nejad N, Fishman EK, Zaheer A. Imaging of post-operative pancreas and complications after pancreatic adenocarcinoma resection. Abdom Radiol (NY). 2018;43(2):476-88.
- Javadi S, Karbasian N, Bhosale P, et al. Imaging findings of recurrent pancreatic cancer following resection. Abdom Radiol (NY). 2018;43(2):489-96.
- Javed AA, Bleich K, Bagante F, et al. Pancreaticoduodenectomy with venous resection and reconstruction: current surgical techniques and associated postoperative imaging findings. Abdom Radiol (NY). 2018;43(5):1193-203.
- Kambadakone AR, Zaheer A, Le O, et al. Multi-institutional survey on imaging practice patterns in pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2018;43(2):245-52.
- Kawamoto S, Fuld MK, Laheru D, Huang P, Fishman EK. Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT. Abdom Radiol (NY). 2018;43(2):445-56.
- Koay EJ, Hall W, Park PC, Erickson B, Herman JM. The role of imaging in the clinical practice of radiation oncology for pancreatic cancer. Abdom Radiol (NY). 2018;43(2):393-403.
- Kulkarni NM, Hough DM, Tolat PP, Soloff EV, Kambadakone AR. Pancreatic adenocarcinoma: cross-sectional imaging techniques. Abdom Radiol (NY). 2018;43(2):253-63.
- Lindquist CM, Miller FH, Hammond NA, Nikolaidis P. Pancreatic cancer screening. Abdom Radiol (NY). 2018;43(2):264-72.
- Parakh A, Patino M, Muenzel D, Kambadakone A, Sahani DV. Role of rapid kV-switching dual-energy CT in assessment of post-surgical local recurrence of pancreatic adenocarcinoma. Abdom Radiol (NY). 2018;43(2):497-504.
- Patel BN, Olcott E, Jeffrey RB. Extrapancreatic perineural invasion in pancreatic adenocarcinoma. Abdom Radiol (NY). 2018;43(2):323-31.
- Patel BN, Olcott EW, Jeffrey RB. Duodenal invasion by pancreatic adenocarcinoma: MDCT diagnosis of an aggressive imaging phenotype and its clinical implications. Abdom Radiol (NY). 2018;43(2):332-9.
- Rashid MF, Hecht EM, Steinman JA, Kluger MD. Irreversible electroporation of pancreatic adenocarcinoma: a primer for the radiologist. Abdom Radiol (NY). 2018;43(2):457-66.
- Rayamajhi S, Balachandran A, Katz M, Reddy A, Rohren E, Bhosale P. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma. Abdom Radiol (NY). 2018;43(2):505-13.
- Soloff EV, Zaheer A, Meier J, Zins M, Tamm EP. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease. Abdom Radiol (NY). 2018;43(2):301-13.
- Steinman J, Zaheer A, Kluger MD, Remotti H, Hecht EM. Rare pancreatic tumors. Abdom Radiol (NY). 2018;43(2):285-300.
- Tamm EP. Introduction to the special section on pancreatic cancer. Abdom Radiol (NY). 2018;43(2):243-4.
- Vergauwen MAT, Perillo M, Garces-Descovich A, Barrows CE, Moser AJ, Mortele KJ. Radiologic evaluation of patients undergoing the modified Appleby procedure for locally advanced pancreatic neoplasms: a case series. Abdom Radiol (NY). 2018;43(2):467-75.
- Yeh R, Dercle L, Garg I, Wang ZJ, Hough DM, Goenka AH. The Role of 18F-FDG PET/CT and PET/MRI in Pancreatic Ductal Adenocarcinoma. Abdom Radiol (NY). 2018;43(2):415-34.
Please follow our social media accounts for up to date publications and information related to pancreatic cancer and our DFP’s various initiatives.
The Society of Abdominal Radiology official Twitter account can be found at https://twitter.com/SocAbdRadiology
Templates and Imaging Protocols
National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines, including pancreatic cancer: https://www.nccn.org/evidenceblocks/default.aspx
ACR Appropriateness Criteria for staging and post-neoadjuvant therapy follow-up of pancreatic ductal adenocarcinoma: https://acsearch.acr.org/docs/3099847/Narrative/
Links for Patients
Pancreatic Cancer Action Network (PANCAN): https://www.pancan.org/facing-pancreatic-cancer/patient-services/
National Comprehensive Cancer Network (NCCN) Guidelines for Patients: https://www.nccn.org/patients/guidelines/content/PDF/pancreatic-patient.pdf
SAR Pelvic Floor Dysfunction DFP
The mission of the SAR’s Pelvic Floor Dysfunction Disease-focused Panel is to engage expert pelvic floor radiologists and clinicians in the fields of urology, urogynecology, gastroenterology, colorectal surgery, and physical medicine and rehabilitation to help bridge current gaps in understanding, and standardize indications, acquisition techniques, and reporting of pelvic floor imaging.
The broad objectives of this DFP are to develop educational materials, joint recommendations, and scientific collaborations that will impact patient care and improve imaging of pelvic floor dysfunction.
Improvements in patient care
1. Diagnosis – Correlate physical examination (Pelvic Organ Prolapse Quantification criteria) and surgical findings with radiology findings on MRI, fluoroscopic defecography, and ultrasound.
2. Establish “normal” and abnormal MRI appearance of the pelvic floor in asymptomatic controls and symptomatic patients.
3. Evaluate and enhance imaging techniques in patients with implanted surgical material in the pelvis.
a. Urethral bulking agents
b. Urethral slings
c. Vaginal mesh
4. Correlate imaging findings on MRI with those on ultrasound in patients presenting with complications post pelvic floor repair with mesh, slings, and urethral bulking agents.
Improvements in radiology practice
5. Assess current use of imaging for pelvic floor dysfunction across various radiology departments nationally and internationally.
6. Standardize radiological techniques and protocols for assessment of pelvic floor dysfunction.
a. Application of ACR appropriateness criteria
b. Standardized nomenclature and reporting criteria/templates
c. Improve reproducibility and consistency of study performance technique across institutions with focus on MRI, fluoroscopy, and ultrasound
d. Consider how different techniques affect threshold values and diagnostic accuracy
7. Develop strategies for education of and collaboration between radiologists, technologists, and referring physicians regarding the utility and application of imaging in pelvic floor dysfunction
SAR Pelvic Floor Dysfunction DFP Members:
Hina Arif, MD
Simin Bahrami, MD
Victoria Chernyak, MD
Rania Farouk El Sayed, MD, PhD
Julia R. Fielding, MD
Milana Flusberg, MD
Phyllis Glanc, MD
Marta Heilbrun, MD (liaison on oversight committee)
Kedar Jambhekar, MD
Amita Kamath, MD, MPH
Devaraju Kanmaniraha, MD
Gaurav Khatri, MD
Neeraj Lalwani, MD
Susanna Lee, MD (liaison on oversight committee)
Sara Lewis, MD
Mark Lockhart, MD, MPH
Dean Maglinte, MD
Suzanne Palmer, MD
Harpeet Pannu, MD
Roopa Ram, MD
Alison Sheridan, MD
Francis Scholz, MD
Ari Steiner, MD
Larissa Rodriguez, MD, Primary
Philippe Zimmern, MD, Secondary
Gaurav Khatri, MD and Kedar Jambhekar, MD, Co-Chairs
1. Survey of national and international radiology departments
2. Development of standardized dictation templates for imaging of pelvic floor dysfunction
3. Collaboration with ESUR and other clinical societies
Information for patients:
RadiologyInfo MRI- Dynamic Pelvic Floor (web version)
American College of Radiology Appropriateness Criteria
DFP Recommended Templates
MR Defecography Template
XR Defecography Template
DFP Recommended Protocols
MR Defecography Protocol: https://abdominalradiology.org/wp-content/uploads/2020/11/MRDefProtocol.02282018.pdf
Mission: The SAR Prostate Cancer Disease-Focused Panel will collaborate with radiologists, urologists, oncologists, radiation oncologists and other groups to improve the care of patients with known or suspected prostate cancer through the clinical incorporation of optimized imaging techniques for prostate cancer detection, staging, and management.
1. Establish and uphold formal collaborations with other clinical and medical societies to develop clinical practice guidelines, position statements and other communications related to the contemporary practices of imaging in prostate cancer.
2. Create and continuously update educational materials for an audience and readership interested in imaging of prostate cancer.
3. Build a continuously updating resource of current research and educational materials in various aspects of contemporary prostate cancer imaging.
4. To support and value a culture of inclusion, foster diversity and actively promote inclusion at all levels of training, practice, and leadership.
SAR Prostate Cancer Disease-Focused Panel Members (in alphabetical order):
Sandeep Arora, MD
Jelle Barentsz, MD, PhD *
Tharak Bathala, MD
Bijan Bijan, MD
Leonardo Bittencourt, MD, PhD
David Casalino, MD
Silvia Chang, MD, FRCPC, FSAR
Peter Choyke, MD *
Fergus Coakley, MD *
Steven Eberhardt, MD
Adam Froemming, MD
Jurgen Futterer, MD, PhD
Dhakshina Moorthy Ganeshan, MD
Lori Gettle, MD MBA
Soleen Ghafoor, MD
Sangeet Ghai, MD
Rajan Gupta, MD
Michael Hahn, MD
Masoom Haider, MD, FRCPC *
Mukesh Harisinghani, MD *
Thomas Hope, MD
Chan Kyo Kim, MD
Chandana Lall, MD
Thomas Loehfelm, MD PhD
Daniel Margolis, MD *
Leonard Marks, MD
Refky Nicola, MS DO
Aytekin Oto, MD *
Rosaleen Parsons, MD
Nayana Patel, MD
Andrei Purysko, MD
Andrew Rosenkrantz, MD *
Prasad Shankar, MD
Benjamin Spilseth, MD
Shilpa Surasi, MD
Varaha Tamisetti, MD
Nelly Tan, MD
Angela Tong, MD
Ismail Baris Turkbey, MD
Alberto Vargas, MD *
Sadhna Verma, MD *
Antonio Westphalen, MD, PhD
Jinxing Yu, MD
Ronald Zagoria, MD, FACR *
* Senior Advisor/Mentor
Silvia Chang, MD, FRCPC, FSAR, Co-Chair
Antonio C. Westphalen MD, PhD, Co-Chair
- Clinical practice: Rajan Gupta, MD and Jinxing Yu, MD
- Education: Andrei Purysko, MD and Varaha S. Tammisetti, MD
- Research and AI: Masoom Haider, MD, FRCPC and Baris Turkbey, MD
- Engagement, Social Media and Website: Soleen Ghafoor, MD
- Online case-based education director: Varaha S. Tammisetti, MD
- Prostate Hands-on Workshop (co-)directors: Sandeep Arora, MD
- MDT Symposium coordinator: Tharak Bathala, MD
- Outreach: Chan Kyo Kim, MD and Nayana Patel, MD
- Diversity: Chandana Lall, MD and Daniel Margolis, MD
- Liaison to ESUR: Jurgen Futterer, MD, PhD
- Liaison to AUA: Jinxing Yu, MD
- Liaison to ACR PI-RADS steering committee: Rajan Gupta, MD
- Liaison to SIR: Sangeet Ghai, MD
- Liaison to SNMMI: Thomas Hope, MD
- Liaison to ASAR: Chan Kyo Kim, MD
- Liaison to Central and South American Societies: Leonardo Bittencourt, MD, PhD
- Consultant urologist: Leonard Marks, MD
12/21/2020: Does MRI/US fusion target biopsy overestimate the Gleason score (GS) of PCa?
Submitted by Jinxing YU, MD, Virginia Commonwealth University Richmond
12/14/2020: Radiologic Progression of Disease in a patient on Active Surveillance of Prostate Adenocarcinoma
Submitted by Valarie Sands, MD and Steven Eberhardt, MD, University of New Mexico Hospital
11/30/2020: Quality Control Process for Prostate MRI and MRI Guided Biopsy Procedures
Submitted by Baris Turkbey, MD, National Cancer Institute
11/9/2020: Utility of Mutiparametric MRI in an Exceedingly Rare Presentation of Metastatic Prostate Cancer
Submitted by Rosaleen Parsons, MD, Fox Chase Cancer Center Philadelphia
11/2/2020: Value of mpMRRI + MR-TRUS Fusion Targeted Biopsy During Active Surveillance
Submitted by Leonardo Kayat Bittencourt, University Hospitals
10/26/2020: Case of the Week
Submitted by David J A Margolis, MD, and Fernanda Mazzariol, MD
09/21/2020: Recurrent Prostate Cancer in Seminal Vesicles in a Patient with Brachytherapy: mpMRI and PSMA PET Findings
Submitted by Baris Turkbey, MD, National Cancer Institute, NIH, Bethesda, MA
09/14/2020: Extranodal Marginal Zone Lymphoma of MALT in Prostate
Submitted by Chan Kyo Kim, MD, Professor of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine
09/07/2020: Pelvic mass: Paraganglioma
Submitted by Nayana Patel, MD, Associate Professor or Radiology, Director of Abdominal Imaging Fellowship, University of Colorado Anschutz Medical Campus
08/10/2020: Post Radiation Induced Sarcoma
Submitted by Mukesh Harisinghani, MD, FACR, Professor of Radiology, Massachusetts General Hospital
07/27/2020: Pitfall in the interpretation of the Prostate: Artefact due ot mispositioned endorectal coil
Submitted by Tharak Bathala, MD, Janio Szklaruk, MD, Professor, Department of Imaging Physics, MD Anderson Cancer Center
07/20/2020: Tumor Recurrence After Whole Gland HIFU Ablation of the Prostate Gland
Submitted by Angela Tong, MD, NYU Langone Health
07/13/2020: Basal Cell Carcinoma of the Prostate
Submitted by Mizba Baksh and David D. Casalino, MD, Northwestern University
06/29/2020: Prostatic Adenocarcinoma with Indicental Schwannoma
Submitted by Yan Mee Law, MBBS, FRCR, SIngapore General Hospital
06/22/2020: Incidental Prostate Cancer on Rectal MRI
Submitted by Varaha Sai Tammisetti, MD, University of Texas Health Science Center at Houston
06/15/2020: Impact of Motion on Quality of T2W Prostate MRI
Submitted by Baris Turkbey, MD, National Cancer Institute
06/08/2020: Unilateral Seminal Vesicle Agenesis
Submitted by Baris Turkbey, MD, National Cancer Institute
06/01/2020: Incidental Prostate Cancer after HoLEP
Submitted by Theodora A. Potretzke, MD, and Adam Froemming, MD, Mayo Clinic Rochester
01/27/2020: Use of MRI in Persistent/Recurrent Prostate Cancer After Systemic and Ablative Treatments
Submitted by Katie L. Gardner, DO, and Steven C. Eberhardt, MD, University of New Mexico Hospital
01/20/2020: Prostate DFP Case – January 20, 2020
Submitted by Nayana Patel, MD, FSAR, University of Colorado
01/13/2020: Granulomatous Prostatitis
Submitted by Leonardo Kayat Bittencourt
01/06/2020: Mimicker of Prostate Cancer
Submitted by Silva D. Chang, MD, FRCPC, FSAR, University of British Columbia
General updates and active projects
COVID-19 Impact on Prostate MRI and Guided Biopsy Operations-SAR DFP Survey – led by Shilpa Surasi, MD
Workshops – current and future only
Templates and Imaging Protocols
Links for patients
Resources and Article Database
LINK: (ACR – https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/PI-RADS)
MISSIONS AND GOALS:
To define the role and incremental value of various imaging modalities (including MRI, endorectal ultrasound, PET-CT, PET-MR, and molecular imaging) in the detection and staging of rectal and anal cancer.
To enhance treatment and positive outcome in patients with primary rectal and anal cancer, through education, imaging technique optimization, report standardization and multidisciplinary research collaboration
Educational: To provide basic and periodically updated, evidence-based information regarding
- Optimal imaging techniques, standardized vendor-specific protocols, and technical standards for staging and re-staging.
- Address the role of non-MRI rectal and anal cancer staging (US, CT, and PET-CT).
- Standards of reporting.
Patient Care: To form alliances with medical, surgical and radiation oncology groups to reach consensus on the role of imaging, and approaches to improve patient outcomes.
Research: Promote and encourage international research collaboration within and outside radiology.
Current Leadership Team:
Marc Gollub, MD, FACR (gollubm@MSKCC.ORG)
Mukesh Harisinghani, MD, FACR (firstname.lastname@example.org), Co-Chairs
SAR Rectal and Anal Cancer DFP Members:
Marc J. Gollub, MD, FACR – Chair (gollubm@MSKCC.ORG)
Professor of Radiology
Director, Section of CT
Department of Radiology
Memorial Sloan Kettering Cancer Center
Mukesh Harisinghani, MD, FACR – Co-Chair
Supreeta Arya, MD
David D.B. Bates, MD (email@example.com)
Kevin J. Chang, MD, FACR, FSAR (Kevin.J.Chang@gmail.com)
Courtney Coursey Moreno, MD (firstname.lastname@example.org)
Greg DePrisco, MD (email@example.com)
Randy D. Ernst, MD (firstname.lastname@example.org)
Dhakshina Ganeshan, MD (DGaneshan@mdanderson.org)
Jennifer S. Golia Pernicka, MD (email@example.com)
Kartik S. Jhaveri, MD, FRCPC (Kartik.Jhaveri@uhn.ca)
Thomas A. Hope, MD (firstname.lastname@example.org)
Natally Horvat, MD, PhD (email@example.com)
Zahra Kassam, MD, FRCPC (firstname.lastname@example.org)
Harmeet Kaur, MD (email@example.com)
Gaurav Khatri, MD (firstname.lastname@example.org)
David H. Kim, MD (email@example.com)
Elena Korngold (firstname.lastname@example.org)
Tyler J. Fraum, MD (email@example.com)
Chandana (Sandy) Lall, MD, MBA, FSAR (firstname.lastname@example.org)
Neeraj Lalwani (email@example.com)
Stephanie Nougaret, MD, PhD (Stephanie.Nougaret@icm.unicancer.fr)
Viktoriya Paroder MD, PhD (firstname.lastname@example.org)
Raj Mohan Paspulati, MD, FSAR (email@example.com)
Iva Petkovska, MD (firstname.lastname@example.org)
Perry J. Pickhardt, MD (PPickhardt2@uwealth.org)
Gaiane (Maia) Margishvili Rauch, MD, PhD (GMRauch@mdanderson.org)
Michael H Rosenthal, MD, PhD (email@example.com)
Hiram Shaish, MD (firstname.lastname@example.org)
Shannon P. Sheedy, MD (Sheedy.Shannon@mayo.edu)
Sonia Lee, MD (email@example.com)
Assistant Clinical Professor
Radiological Sciences School of Medicine
University of California, Irvine
Regina Beets-Tan, MD PhD (firstname.lastname@example.org) – International liaison
Department of Radiology
Netherlands Cancer Institute
Amsterdam, The Netherlands
GROW School for Oncology and Developmental Biology
Maastricht, The Netherlands
Sunil Krishna – (Krishnan.Sunil@mayo.edu)
MD Anderson Cancer Center
Radiation Oncology Consultant
David Patrick Ryan – (DPRYAN@mgh.harvard.edu ) – Medical Oncology Consultant
Chief, Hematology/Oncology Clinical Director
Mass General Cancer Center
Martin Weiser – ( email@example.com ) – Surgical Consultant
Attending Surgical Oncologist
Vice Chair for Education and Faculty Development, Department of Surgery; Stuart H.Q. Quan Chair in Colorectal Surgery
Memorial Sloan Kettering Cancer Center
Kenneth Friedman (Kenneth.Friedman@uhhospitals.org) – Pathology Consultant
Assistant Professor of Pathology
University Hospitals, Case Western Reserve University
Jingfei Ma, Ph.D. (firstname.lastname@example.org) – Physics Consultant
Professor, Department of Imaging Physics
The University of Texas
Anderson Cancer Center
Regular Faculty, Medical Physics Program
University of Texas
Graduate School of Biomedical Sciences
General Updates and Active Projects
1. Contributions to Educational Program for the SAR Annual Meeting.
2. Anal Cancer Report Template.
3. Several multicenter study initiatives are ongoing including PET/MR, Mucinous tumors and Inter-reader evaluation of DWI in non-operative management cases.
- SAR 2021 Hands- On
- ARRS 2020 Virtual Hands-On – November 6th, 2020
Twitter: @ SARDFPRECTAL
TEMPLATES AND IMAGING PROTOCOLS
- MRI Anal Squamous Cell Cancer Baseline Staging Template
- MRI Primary Rectal Cancer Staging Template
- MRI Primary Rectal Cancer Restaging Template
- User’s Guide to Synoptic Staging Template
- Essentials of Cancer – Anatomy Atlas
LINKS FOR PATIENTS
SAR Renal Cell Carcinoma (RCC) Disease-Focused Panel (DFP)
1. To advance the radiologic research contributions to the diagnosis and management of both localized and advanced renal cell carcinoma.
2. Create clinical practice and educational materials for healthcare personnel interested in imaging of renal cancer.
- Develop and validate non-invasive methods to assess biologic behavior of renal masses, and discriminate both benign from malignant and aggressive from indolent cancers.
- Compare and validate image-based criteria for the assessment of treatment response in advanced renal cell carcinoma.
- Educate radiologists and non-radiologists on the role of imaging in the management of suspected, localized, and advanced renal cell carcinoma.
- Co-Chairs: Matthew Davenport, MD, & Ivan Pedrosa, MD PhD
- Matthew S. Davenport, MD, Associate Professor of Radiology and Urology (University of Michigan)
- Ivan Pedrosa, MD, PhD, Professor of Radiology, Urology, and Advanced Imaging Research Center (UT Southwestern Medical Center)
- Ronaldo Hueb Baroni, MD, Professor of Radiology (Albert Einstein Medical School)
- Richard Barr, MD, PhD, Professor of Radiology (Northeast Ohio Medical University)
- Hersh Chandarana, MD, Associate Professor of Radiology (NYU Langone Health)
- Wui Chong, MD, Associate Professor of Radiology (MD Anderson Cancer Center)
- Nicole E. Curci, MD, Assistant Professor of Radiology (University of Michigan)
- Ankur Doshi, MD, Assistant Professor of Radiology (NYU Langone Health)
- Elizabeth Edney, MD, Assistant Professor of Radiology (University of Nebraska)
- David T. Fetzer, MD, Assistant Professor of Radiology (UT Southwestern)
- Nicole Hindman, MD, Associate Professor of Radiology and Surgery (NYU Langone Health)
- Gary M. Israel, MD, Professor of Radiology (Yale School of Medicine)
- Satheesh Krishna, MD, Assistant Professor of Radiology, Medical Imaging (University of Toronto)
- Steven S. Raman, MD, Professor of Radiology, Urology & Surgery (UCLA Medical Center)
- Erick M. Remer, MD FACR, Professor of Radiology (Cleveland Clinic)
- Nicola Schieda, MD, FRCPC, Assistant Professor of Radiology (University of Ottawa)
- Atul Shinagare, MD, Associate Professor of Radiology (Brigham and Women’s Hospital/Harvard University)
- Stuart G. Silverman, MD, Professor of Radiology (Brigham and Women’s Hospital/Harvard University)
- Andrew D. Smith, MD PhD, Associate Professor of Radiology (University of Alabama – Birmingham)
- Raghunandan Vikram, MBBS, MRCP, FRCR, Associate Professor of Radiology (MD Anderson Cancer Center)
- Zhen J. Wang, MD, Professor, Radiology (University of California at San Francisco)
- Stefanie Weinstein, MD, Associate Professor of Radiology (University of California at San Francisco)
- Shane Wells, MD, Associate Professor of Radiology (University of Wisconsin School of Medicine and Public Health)
SAR RCC CONSULTANTS:
- Samuel Kaffenberger, MD, Assistant Professor of Urology (University of Michigan)
GENERAL UPDATES AND ACTIVE PROJECTS
SAR Workshops (to be presented 2021):
- Hands-on workshop at the SAR annual meeting (2019-2021): Advanced Renal Mass Imaging
- Bosniak v.2019
- Locally advanced renal cell carcinoma
No active content at present
Templates and Imaging Protocols:
- Standardized imaging protocols for evaluating renal masses and renal cancers have been poster on the SAR RCC DFP website:
- Standardized report template is posted on the SAR RCC DFP website:
- A link with kidney cancer Information for health providers is posted on the SAR RCC DFP website: http://www.cancer.gov/types/kidney/hp
Bosniak v2019 Online calculator:
- Please post calculator posted on current DFP webpage. Please link same calculator to new / updated webpage. Please contact Satheesh (SatheeshKrishna.Jeyaraj@uhn.ca) from our DFP for any help needed re: this transition (he designed it).
- Website: https://bosniak-calculator.herokuapp.com/
- Android app: https://play.google.com/store/apps/details?id=com.bosniakcalculator
- iOS app: https://apps.apple.com/us/app/id1529618418
Links for patients:
- Kidney Cancer Information for Patients: http://www.cancer.gov/types/kidney
Mission and Goals
- To foster education, mentorship, and networking between radiologists and referring clinicians dedicated to reducing morbidity and mortality for patients with uterine and ovarian cancer.
- To promote cutting edge research through multispecialty collaborations on all aspects of management of women with uterine and ovarian cancers, into order to improve outcomes in women with gynecologic cancers.
- To facilitate widespread adoption of efficacious advanced imaging methods in uterine and ovarian cancer and address current practice gaps in radiologists’ knowledge in the field of multi-modality uterine and ovarian imaging.
- Collaborate with clinical subspecialty societies to address patient care initiatives, establish and promote best practice guidelines, and promote improved medical decision making through medical imaging in the care of women with uterine and ovarian cancers.
Leadership and membership
Founding Chairs: Evis Sala and Elizabeth Sadowski
Current leadership (2019-21): Chair, Alberto Vargas; Vice chair, Kate Maturen
General updates and active projects
Current multi-institutional research projects:
- Adnexal Cyst Characterization and Management (Sadowski and Maturen)
- Incidental Adnexal Lesions in Oncology Patients (Shinagare)
- Early Ovarian Cancer on CT/MR/US (Sadowski)
Clinical practice guidelines under development:
- ESUR/SAR Placental Imaging Guidelines (Jha and Poder)
- Ovarian Cancer Staging Lexicon and Dictation Template (Shinagare and Sadowski)
- SAR/ABS Intersociety Brachytherapy Imaging Guidelines (Venkatesan and Rauch)
- Active collaborations with other organizations
- ACR O-RADS (Ovarian and Adnexal Reporting And Data System) for US and MRI
- ACR Appropriateness Criteria Expert Panel on Gynecologic and Obstetric Imaging
- Upcoming in June 2021, Uterine and Ovarian Cancer DFP Webinar, Details TBA
- December 2020, RSNA, “Ovarian Cancer Imaging: Radiologists as
- Partners in Cancer Care” Featured Course
- December 2019, RSNA, "Imaging with Impact in Gynecologic Oncology" Series Course
- March 2018, SAR, “Advanced Female Pelvic Imaging” Hands On Course
- March 2017, SAR, “Advanced Female Pelvic Imaging” Hands On Course
- March 2016, SAR, “Advanced Female Pelvic Imaging” Hands On Course
UOC DFP New Member Application: Click here
UOC DFP FACEBOOK PAGE: Click here
UOC DFP Twitter: Follow @SARpelvicDFPs
Templates and Imaging Protocols
UOC DFP Dictation Templates:
UOC DFP MRI Scanning Protocols:
Links for patients